10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2016
	OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ______________TO_______________

Commission File Number: 001-00652

UNIVERSAL CORPORATION

(Exact name of registrant as specified in its charter)

Virginia (State or other jurisdiction of incorporation or organization)	54-0414210 (I.R.S. Employer Identification Number)
9201 Forest Hill Avenue, Richmond, Virginia (Address of principal executive offices)	23235 (Zip Code)

804-359-9311

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes þNo o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þNo o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer þ Accelerated filer o Non-accelerated filer o Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

As of February 3, 2017, the total number of shares of common stock outstanding was 25,273,449.

UNIVERSAL CORPORATION

FORM 10-Q

TABLE OF CONTENTS

Item No.		Page
	PART I - FINANCIAL INFORMATION
1.	Financial Statements	3
2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	25
3.	Quantitative and Qualitative Disclosures About Market Risk	30
4.	Controls and Procedures	31
	PART II - OTHER INFORMATION
1.	Legal Proceedings	32
1A.	Risk Factors	32
2.	Unregistered Sales of Equity Securities and Use of Proceeds	32
6.	Exhibits	33
	Signatures	34

2

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

UNIVERSAL CORPORATION

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(in thousands, except share and per share data)

	Three Months Ended December 31,						Nine Months Ended December 31,
	2016			2015			2016			2015
	(Unaudited)						(Unaudited)
Sales and other operating revenues	$	668,771		$	584,592		$	1,421,188		$	1,316,393
Costs and expenses
Cost of goods sold	533,318			464,686			1,145,694			1,050,004
Selling, general and administrative expenses	52,068			54,081			153,101			166,187
Other income	—			(3,390		)	—			(3,390		)
Restructuring and impairment costs	178			—			3,860			2,389
Operating income	83,207			69,215			118,533			101,203
Equity in pretax earnings of unconsolidated affiliates	4,495			2,326			5,625			2,556
Interest income	482			452			1,116			896
Interest expense	4,051			3,937			12,440			11,733
Income before income taxes	84,133			68,056			112,834			92,922
Income tax expense	27,071			21,441			36,778			27,368
Net income	57,062			46,615			76,056			65,554
Less: net income attributable to noncontrolling interests in subsidiaries	(3,415		)	(2,081		)	(2,621		)	(4,502		)
Net income attributable to Universal Corporation	53,647			44,534			73,435			61,052
Dividends on Universal Corporation convertible perpetual preferred stock	(3,687		)	(3,687		)	(11,061		)	(11,061		)
Earnings available to Universal Corporation common shareholders	$	49,960		$	40,847		$	62,374		$	49,991
Earnings per share attributable to Universal Corporation common shareholders:
Basic	$	2.17		$	1.80		$	2.73		$	2.20
Diluted	$	1.92		$	1.60		$	2.63		$	2.18
Weighted average common shares outstanding:
Basic	22,982,473			22,717,043			22,831,717			22,671,943
Diluted	27,996,583			27,854,908			27,967,215			22,957,050
Total comprehensive income, net of income taxes	$	58,717		$	47,794		$	76,038		$	69,644
Less: comprehensive income attributable to noncontrolling interests, net of income taxes	(3,214		)	(2,042		)	(1,976		)	(4,037		)
Comprehensive income attributable to Universal Corporation, net of income taxes	$	55,503		$	45,752		$	74,062		$	65,607
Dividends declared per common share	$	0.54		$	0.53		$	1.60		$	1.57

See accompanying notes.

3

UNIVERSAL CORPORATION     

CONSOLIDATED BALANCE SHEETS

(in thousands of dollars)

	December 31,			December 31,			March 31,
	2016			2015			2016
	(Unaudited)			(Unaudited)
ASSETS
Current assets
Cash and cash equivalents	$	411,507		$	167,625		$	319,447
Accounts receivable, net	280,978			267,632			428,659
Advances to suppliers, net	93,175			84,905			101,890
Accounts receivable—unconsolidated affiliates	2,073			762			2,316
Inventories—at lower of cost or market:
Tobacco	736,368			965,917			637,132
Other	67,638			65,123			60,888
Prepaid income taxes	11,419			16,359			17,814
Other current assets	61,856			67,456			70,400
Total current assets	1,665,014			1,635,779			1,638,546
Property, plant and equipment
Land	22,760			22,870			22,987
Buildings	264,485			256,970			264,838
Machinery and equipment	603,860			591,292			591,327
	891,105			871,132			879,152
Less: accumulated depreciation	(569,697		)	(545,518		)	(553,265		)
	321,408			325,614			325,887
Other assets
Goodwill and other intangibles	98,869			99,035			99,071
Investments in unconsolidated affiliates	75,574			75,351			82,441
Deferred income taxes	24,266			38,750			23,853
Other noncurrent assets	41,798			52,245			61,379
	240,507			265,381			266,744
Total assets	$	2,226,929		$	2,226,774		$	2,231,177

See accompanying notes.

4

UNIVERSAL CORPORATION     

CONSOLIDATED BALANCE SHEETS

(in thousands of dollars)

	December 31,			December 31,			March 31,
	2016			2015			2016
	(Unaudited)			(Unaudited)
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Notes payable and overdrafts	$	52,052		$	65,894		$	66,179
Accounts payable and accrued expenses	131,925			132,572			120,527
Accounts payable—unconsolidated affiliates	10,522			21,768			8,343
Customer advances and deposits	14,201			41,209			16,438
Accrued compensation	22,800			20,681			27,593
Income taxes payable	7,239			5,893			7,190
Current portion of long-term debt	—			—			—
Total current liabilities	238,739			288,017			246,270
Long-term debt	368,645			368,292			368,380
Pensions and other postretirement benefits	78,930			90,643			92,177
Other long-term liabilities	30,038			33,179			41,794
Deferred income taxes	29,075			27,447			29,494
Total liabilities	745,427			807,578			778,115
Shareholders’ equity
Universal Corporation:
Preferred stock:
Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, none issued or outstanding	—			—			—
Series B 6.75% Convertible Perpetual Preferred Stock, no par value, 220,000 shares authorized, 107,418 shares issued and outstanding (218,490 at December 31, 2015 and March 31, 2016)	104,012			211,562			211,562
Common stock, no par value, 100,000,000 shares authorized, 25,270,976 shares issued and outstanding (22,717,448 at December 31, 2015, and 22,717,735 at March 31, 2016)	319,509			206,941			208,946
Retained earnings	1,090,148			1,033,986			1,066,064
Accumulated other comprehensive loss	(71,723		)	(70,439		)	(72,350		)
Total Universal Corporation shareholders' equity	1,441,946			1,382,050			1,414,222
Noncontrolling interests in subsidiaries	39,556			37,146			38,840
Total shareholders' equity	1,481,502			1,419,196			1,453,062
Total liabilities and shareholders' equity	$	2,226,929		$	2,226,774		$	2,231,177

See accompanying notes.

5

UNIVERSAL CORPORATION     

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of dollars)

	Nine Months Ended December 31,
	2016			2015
	(Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	76,056		$	65,554
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	26,107			27,221
Net provision for losses (recoveries) on advances and guaranteed loans to suppliers	414			(1,026		)
Foreign currency remeasurement loss (gain), net	12,493			21,492
Fair value gain upon acquisition of partner's interest in joint venture	—			(3,390		)
Restructuring and impairment costs	3,860			2,389
Other, net	7,290			18,004
Changes in operating assets and liabilities, net	56,533			(120,045		)
Net cash provided by operating activities	182,753			10,199
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment	(28,544		)	(38,504		)
Purchase of partner's interest in joint venture, net of cash held by the business	—			(5,964		)
Proceeds from sale of property, plant and equipment	665			1,380
Other	—			(398		)
Net cash used by investing activities	(27,879		)	(43,486		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance (repayment) of short-term debt, net	(11,299		)	4,168
Dividends paid to noncontrolling interests	(1,260		)	(1,260		)
Dividends paid on convertible perpetual preferred stock	(11,061		)	(11,061		)
Dividends paid on common stock	(36,181		)	(35,349		)
Other	(2,256		)	(3,736		)
Net cash used by financing activities	(62,057		)	(47,238		)
Effect of exchange rate changes on cash	(757		)	(633		)
Net increase (decrease) in cash and cash equivalents	92,060			(81,158		)
Cash and cash equivalents at beginning of year	319,447			248,783
Cash and cash equivalents at end of period	$	411,507		$	167,625

Non-cash Financing Transaction - The consolidated financial statements for the nine months ended December 31, 2016 include a non-cash reclassification of $107.6 million from preferred stock to common stock to reflect the conversion of 111,072 shares of the Company's outstanding Series B 6.75% Convertible Perpetual Preferred Stock into common stock. See Note 3 for additional information.

See accompanying notes.

6

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1.   BASIS OF PRESENTATION

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the leading global leaf tobacco supplier. Because of the seasonal nature of the Company’s business, the results of operations for any fiscal quarter will not necessarily be indicative of results to be expected for other quarters or a full fiscal year. All adjustments necessary to state fairly the results for the period have been included and were of a normal recurring nature. Certain amounts in prior year statements have been reclassified to conform to the current year presentation. This Form 10-Q should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2016.

NOTE 2.   ACCOUNTING PRONOUNCEMENTS

Pronouncements Adopted in Fiscal Year 2017

In April 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for fiscal years beginning after December 31, 2015. The Company adopted ASU 2015-03 effective as of April 1, 2016, the beginning of fiscal year 2017. The implementation of ASU 2015-03, which requires retrospective application, resulted in a $1.8 million and $1.6 million reclassification of unamortized debt issuance costs from other noncurrent assets to long-term debt for the comparative prior periods ended December 31, 2015 and March 31, 2016, respectively.

In May 2015, the FASB issued Accounting Standards Update No. 2015-07, "Fair Value Measurement, Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share or its Equivalent" ("ASU 2015-07"). ASU 2015-07 removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient and eliminates certain disclosures for investments that are eligible to be measured at fair value using the net asset value per share practical expedient. The Company adopted ASU 2015-07 effective as of April 1, 2016, the beginning of fiscal year 2017. Disclosures for all periods presented in Note 8 - Fair Value Measurements were adjusted accordingly.

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, "Compensation - Stock Compensation" ("ASU 2016-09"). ASU 2016-09 provides simplification for the accounting for employee stock-based payment transactions, including the related income tax consequences, treatment of excess tax benefits in determining income tax expense, the classification of awards as either equity or liabilities, and the classification of transactions in the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2017, with early adoption permitted. The Company early adopted ASU 2016-09 effective as of April 1, 2016. Effective with the adoption of ASU 2016-09, employees that the Company has a statutory requirement to withhold taxes on behalf of can now elect to withhold income taxes upon settlement of stock-based compensation awards up to the maximum statutory tax rate without requiring classification of the awards as a liability. As required by ASU 2016-09, employee tax withholding payments and excess tax benefits resulting from stock-based compensation have been classified as financing activities and operating activities, respectively, in the consolidated statements of cash flows for all periods presented.

Pronouncements to be Adopted in Future Periods

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting principles (“U.S. GAAP”).  ASU 2014-09 was developed under a joint project with the International Accounting Standards Board (“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting Standards.  Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.  The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.  It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management judgment and involve more estimates than the current guidance.  ASU 2014-09 is effective for annual periods beginning after December 15, 2017, including all interim periods within the year of adoption.   Companies are allowed to select between two transition methods:  (1) a full retrospective transition method with the application of the new guidance to each prior reporting period presented, or (2) a retrospective transition method that recognizes the cumulative effect on prior periods at the date of adoption together with additional footnote disclosures. Since the issuance of ASU 2014-09, the FASB has issued several amendments to provide additional supplemental guidance on certain aspects of the original pronouncement.  Universal expects to adopt ASU 2014-09 and the related

7

supplemental amendments effective April 1, 2018, which is the beginning of the fiscal year ending March 31, 2019.  The Company is currently evaluating the impact that the adoption of ASU 2014-09 and the related amendments will have on its consolidated financial statements and has not made a decision on the method of adoption.

In July 2015, the FASB issued Accounting Standards Update No. 2015-11, “Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 requires that most inventory be measured at the lower of cost or net realizable value. ASU 2015-11 defines net realizable value as the "estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal, and transportation." ASU 2015-11 is effective for fiscal years beginning after December 31, 2016. The Company is currently evaluating the impact that the adoption of ASU 2015-11 will have on its consolidated financial statements. ASU 2015-11 will be applied prospectively after the date of adoption, as required by the guidance.

In January 2016, the FASB issued Accounting Standards Update No. 2016-01, “Financial Instruments-Recognition and Measurement of Financial Assets and Financial Liabilities” ("ASU 2016-01"). ASU 2016-01 requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in consolidation of the investee). This guidance is effective for fiscal years beginning after December 15, 2017. The Company is currently evaluating the impact that the adoption of ASU 2016-01 will have on its consolidated financial statements.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires a lessee to recognize lease payment obligations as a lease liability and the corresponding right-of-use asset as a leased asset in the balance sheet for the term of the lease. This guidance supersedes Topic 840 “Leases” and is effective for fiscal years beginning after December 15, 2018. The Company will be required to adopt ASU 2016-02 effective April 1, 2019, which is the beginning of its fiscal year ending March 31, 2020, and is currently evaluating the impact that the updated guidance will have on its consolidated financial statements.

In August 2016, the FASB issued Accounting Standards Update No. 2016-15, "Statement of Cash Flows" ("ASU 2016-15"). ASU 2016-15 is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. This guidance is effective for fiscal years beginning after December 15, 2017, with early adoption permitted. The Company is currently evaluating the impact that the adoption of ASU 2016-15 will have on its consolidated financial statements.

NOTE 3.   GUARANTEES, OTHER CONTINGENT LIABILITIES, AND OTHER MATTERS

Guarantees and Other Contingent Liabilities

Guarantees of Bank Loans and Other Contingent Liabilities

Guarantees of bank loans to tobacco growers for crop financing have long been industry practice in Brazil and support the farmers’ production of tobacco there. The Company's operating subsidiary in Brazil had guarantees outstanding at December 31, 2016, all of which expire within one year. The subsidiary withholds payments due to the farmers on delivery of tobacco and forwards those payments to the third-party banks. Failure of farmers to deliver sufficient quantities of tobacco to the subsidiary to cover its obligations to the third-party banks could result in a liability for the subsidiary under the related guarantees; however, in that case, the subsidiary would have recourse against the farmers. The maximum potential amount of future payments that the Company’s subsidiary could be required to make at December 31, 2016, was the face amount, $35 million including unpaid accrued interest ($27 million at December 31, 2015, and $13 million at March 31, 2016). The fair value of the guarantees was a liability of approximately $2 million at December 31, 2016 ($1 million at December 31, 2015, and $2 million at March 31, 2016). In addition to these guarantees, the Company has other contingent liabilities, primarily related to outstanding letters of credit, totaling approximately $2 million at December 31, 2016.

Value-Added Tax Assessments in Brazil

As further discussed below, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) in connection with their normal operations. In Brazil, VAT is assessed at the state level when green tobacco is transferred between states. The Company’s operating subsidiary there pays VAT when tobaccos grown in the states of Santa Catarina and Parana are transferred to its factory in the state of Rio Grande do Sul for processing. The subsidiary has received assessments for additional VAT plus interest and penalties from tax authorities for the states of Santa Catarina and Parana based on audits of the subsidiary’s VAT filings for specified periods. In June 2011, tax authorities for the state of Santa Catarina issued assessments for tax, interest, and penalties for periods from 2006 through 2009 totaling approximately $15 million. In September 2014, tax authorities for the state of Parana issued an assessment for tax, interest, and penalties for periods from 2009 through 2014 totaling approximately $17 million. Those amounts are based on the exchange rate for the Brazilian currency at December 31, 2016. Management of the

8

operating subsidiary and outside counsel believe that errors were made by the tax authorities for both states in determining all or significant portions of these assessments and that various defenses support the subsidiary’s positions.

With respect to the Santa Catarina assessments, the subsidiary took appropriate steps to contest the full amount of the claims. As of December 31, 2016, a portion of the subsidiary’s arguments had been accepted, and the outstanding assessment had been reduced. The reduced assessment, together with the related accumulated interest through the end of the current reporting period, totaled approximately $14 million (at the December 31, 2016 exchange rate). The subsidiary is continuing to contest the full remaining amount of the assessment. While the range of reasonably possible loss is zero up to the full $14 million remaining assessment, based on the strength of the subsidiary’s defenses, no loss within that range is considered probable at this time and no liability has been recorded at December 31, 2016.

With respect to the Parana assessment, management of the subsidiary and outside counsel challenged the full amount of the claim. A significant portion of the Parana assessment was based on positions taken by the tax authorities that management and outside counsel believe deviate significantly from the underlying statutes and relevant case law. In addition, under the law, the subsidiary’s tax filings for certain periods covered in the assessment were no longer open to any challenge by the tax authorities. In December 2015, the Parana tax authorities withdrew the initial claim, and subsequently issued a new assessment covering the same tax periods. The new assessment totaled approximately $5 million at the December 31, 2016 exchange rate, reflecting a substantial reduction from the original $17 million assessment. Notwithstanding the reduction, management and outside counsel continue to believe that the new assessment is not supported by the underlying statutes and relevant case law and have challenged the full amount of the claim. The range of reasonably possible loss is considered to be zero up to the full $5 million assessment. However, based on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been recorded at December 31, 2016.

In both states, the process for reaching a final resolution to the assessments is expected to be lengthy, and management is not currently able to predict when either case will be concluded. Should the subsidiary ultimately be required to pay any tax, interest, or penalties in either case, the portion paid for tax would generate value-added tax credits that the subsidiary may be able to recover.

Other Legal and Tax Matters

Various subsidiaries of the Company are involved in litigation and tax examinations incidental to their business activities.  While the outcome of these matters cannot be predicted with certainty, management is vigorously defending the matters and does not currently expect that any of them will have a material adverse effect on the Company’s business or financial position.  However, should one or more of these matters be resolved in a manner adverse to management’s current expectation, the effect on the Company’s results of operations for a particular fiscal reporting period could be material.

Advances to Suppliers

In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed, fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement of those inputs. These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances to suppliers in the consolidated balance sheets. In several origins, the Company has made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure. In some years, due to low crop yields and other factors, individual farmers may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of those advances into future crop years. The long-term portion of advances is included in other noncurrent assets in the consolidated balance sheets. Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers totaled $125 million at December 31, 2016, $116 million at December 31, 2015, and $134 million at March 31, 2016. The related valuation allowances totaled $30 million at December 31, 2016, $28 million at December 31, 2015, and $29 million at March 31, 2016, and were estimated based on the Company’s historical loss information and crop projections. The allowances were increased by net provisions of approximately $0.4 million and reduced by net recoveries of $1 million in the nine-month periods ended December 31, 2016 and 2015, respectively. These net provisions and recoveries are included in selling, general, and administrative expenses in the consolidated statements of income. Interest on advances is recognized in earnings upon the farmers’ delivery of tobacco in payment of principal and interest.

Recoverable Value-Added Tax Credits

In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services. In some countries, VAT is a national tax, and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at which the tax is assessed. When tobacco is sold to customers in the country of origin, the operating

9

subsidiaries generally collect VAT on those sales. The subsidiaries are normally permitted to offset their VAT payments against the collections and remit only the incremental VAT collections to the tax authorities. When tobacco is sold for export, VAT is normally not assessed. In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream sales are often not sufficient to fully offset the subsidiaries’ VAT payments. In those situations, unused VAT credits can accumulate. Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time and it is not uncommon for refund applications to be challenged or rejected in part on technical grounds. Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits. Due to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time. The Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred. At December 31, 2016, the aggregate balance of recoverable tax credits held by the Company’s subsidiaries totaled approximately $41 million ($51 million at December 31, 2015, and $52 million at March 31, 2016), and the related valuation allowances totaled approximately $11 million ($19 million at December 31, 2015, and $19 million at March 31, 2016). The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.

Conversion of Series B 6.75% Convertible Perpetual Preferred Stock

In December 2016, holders of 111,072 shares of the Company’s Series B 6.75% Convertible Perpetual Preferred Stock (approximately 50.8% of the outstanding shares) voluntarily exercised their conversion rights under the original issuance terms of the preferred shares. The Company chose to satisfy the full conversion obligation for those preferred shares with shares of its common stock, issuing 2,487,118 common shares at the applicable conversion rate in exchange for the preferred shares tendered. The consolidated balance sheet at December 31, 2016 reflects a non-cash reclassification of $107.6 million from preferred stock to common stock to reflect the conversion of those preferred shares.

On January 9, 2017, the Company announced a mandatory conversion of all 107,418 remaining outstanding shares of the preferred stock after meeting the requirements to initiate the mandatory conversion under the original terms of the preferred shares. The Company chose to satisfy the full conversion obligation for the mandatory conversion in cash, paying approximately $178.4 million for those preferred shares on January 31, 2017 to complete the conversion.

With the completion of the mandatory conversion in January 2017, the Company’s outstanding equity securities consist only of its common stock. Dividend payments on the preferred shares, which previously totaled approximately $15 million annually, have been discontinued. Although the conversions of the preferred stock into common stock or for cash do not impact the Company’s net income, the shares converted for cash under the mandatory conversion in January 2017 will result in a one-time reduction of retained earnings of approximately $74.4 million during the quarter ending March 31, 2017, representing the excess of the conversion cost over the carrying value of those shares. The reduction in retained earnings will also result in a corresponding one-time reduction of earnings available to common shareholders for the quarter and fiscal year ending March 31, 2017 for purposes of determining the amounts reported for basic and diluted earnings per share for those periods.

10

NOTE 4.   RESTRUCTURING AND IMPAIRMENT COSTS

Universal continually reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes. Restructuring and impairment costs are periodically incurred in connection with those activities.     For the reporting periods ended December 31, 2016 and 2015, the majority of restructuring costs incurred related to operations that are part of the Other Regions reportable segment of the Company's Flue-Cured and Burley Tobacco Operations.

Quarter andNine Months Ended December 31, 2016

For the quarter and nine months ended December 31, 2016, the Company recorded restructuring and impairment costs totaling $0.2 million and $3.9 million, respectively, primarily related to the Company's decision to close its tobacco processing facility in Hungary. The Company is now processing tobaccos sourced from Hungary in the Company's facilities in Italy. The restructuring and impairment costs incurred for the change in operations in Hungary included statutory employee termination benefits and impairment charges related to certain property and equipment. Substantially all of the termination benefits were paid before December 31, 2016.

Nine Months Ended December 31, 2015

In the first quarter of fiscal year 2016, the Company recorded restructuring and impairment costs totaling $2.4 million related to the scale back of its operations in Zambia. Those costs included statutory employee termination benefits, impairment charges related to outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment charges on certain property and equipment. The majority of the termination benefits were paid during fiscal year 2016.

11

NOTE 5.   EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:

	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands, except share and per share data)	2016			2015			2016			2015
Basic Earnings Per Share
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$	53,647		$	44,534		$	73,435		$	61,052
Less: Dividends on convertible perpetual preferred stock	(3,687		)	(3,687		)	(11,061		)	(11,061		)
Earnings available to Universal Corporation common shareholders for calculation of basic earnings per share	49,960			40,847			62,374			49,991
Denominator for basic earnings per share
Weighted average shares outstanding	22,982,473			22,717,043			22,831,717			22,671,943
Basic earnings per share	$	2.17		$	1.80		$	2.73		$	2.20
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$	49,960		$	40,847		$	62,374		$	49,991
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	3,687			3,687			11,061			—
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	53,647			44,534			73,435			49,991
Denominator for diluted earnings per share
Weighted average shares outstanding	22,982,473			22,717,043			22,831,717			22,671,943
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock	4,693,155			4,857,262			4,816,904			—
Employee share-based awards	320,955			280,603			318,594			285,107
Denominator for diluted earnings per share	27,996,583			27,854,908			27,967,215			22,957,050
Diluted earnings per share	$	1.92		$	1.60		$	2.63		$	2.18

In December 2016, 111,072 shares of the Company’s Series B 6.75% Convertible Perpetual Preferred Stock were converted into approximately 2.5 million of the Company's common stock. The effect from the conversion on the computation of basic and diluted earnings per share for the three and nine months ended December 31, 2016, is included in the table above. See Note 3 for additional information.

The Company had the following potentially dilutive securities (stock appreciation rights) outstanding for the nine months ended December 31, 2016 and 2015 that were not included in the computation of diluted earnings per share because their exercise price exceeded the market price of the Company's common stock, and thus their effect would have been antidilutive:

	Nine Months Ended December 31,
	2016		2015
Potentially dilutive securities	122,200		133,600
Weighted-average exercise price	$	62.66	$	62.66

12

NOTE 6.   INCOME TAXES

The Company is subject to the tax laws of many jurisdictions. Changes in tax laws or the interpretation of tax laws can affect the Company’s earnings, as can the resolution of pending and contested tax issues. The Company's consolidated effective income tax rate on pretax earnings is affected by a number of factors, including the mix of domestic and foreign earnings, the effect of exchange rate changes on deferred taxes, and the Company’s ability to utilize foreign tax credits.

The Company's consolidated effective income tax rates were approximately 32% and 33% for the quarter and nine months ended December 31, 2016, respectively, compared to approximately 32% and 29% for the quarter and nine months ended December 31, 2015, respectively. The effective rate for the prior year nine-month period was lower primarily due to the effects of changes in currency exchange rates on deferred income tax assets and liabilities of foreign subsidiaries. The effective tax rate for the current year period more closely approximates the 35% U.S. federal statutory rate because the effects of currency exchange rate changes have not been significant.    

NOTE 7.   DERIVATIVES AND HEDGING ACTIVITIES

Universal is exposed to various risks in its worldwide operations and uses derivative financial instruments to manage two specific types of risks – interest rate risk and foreign currency exchange rate risk. Interest rate risk has been managed by entering into interest rate swap agreements, and foreign currency exchange rate risk has been managed by entering into forward foreign currency exchange contracts. However, the Company’s policy also permits other types of derivative instruments. In addition, foreign currency exchange rate risk is also managed through strategies that do not involve derivative instruments, such as using local borrowings and other approaches to minimize net monetary positions in non-functional currencies. The disclosures below provide additional information about the Company’s hedging strategies, the derivative instruments used, and the effects of these activities on the consolidated statements of income and comprehensive income and the consolidated balance sheets. In the consolidated statements of cash flows, the cash flows associated with all of these activities are reported in net cash provided by operating activities.

Hedging Strategy for Interest Rate Risk

In January 2015, the Company entered into receive-floating/pay-fixed interest rate swap agreements that were designated and qualified as hedges of the exposure to changes in interest payment cash flows created by fluctuations in variable interest rates on two outstanding non-amortizing bank term loans. Although no significant ineffectiveness is expected with this hedging strategy, the effectiveness of the interest rate swaps is evaluated on a quarterly basis. At December 31, 2016, the total notional amount of the interest rate swaps was $370 million, which corresponded with the aggregate outstanding balance of the term loans.

Cash Flow Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Forecast Purchases of Tobacco and Related Processing Costs

The majority of the tobacco production in most countries outside the United States where Universal operates is sold in export markets at prices denominated in U.S. dollars. However, purchases of tobacco from farmers and most processing costs (such as labor and energy) in those countries are usually denominated in the local currency. Changes in exchange rates between the U.S. dollar and the local currencies where tobacco is grown and processed affect the ultimate U.S. dollar cost of the processed tobacco. From time to time, the Company enters into forward contracts to sell U.S. dollars and buy the local currency at future dates that coincide with the expected timing of a portion of the tobacco purchases and processing costs. This strategy offsets the variability of future U.S. dollar cash flows for tobacco purchases and processing costs for the foreign currency notional amount hedged. This hedging strategy has been used mainly for tobacco purchases and processing costs in Brazil. The aggregate U.S. dollar notional amount of forward contracts entered for these purposes during the first nine months of fiscal years 2017 and 2016 was as follows:

	Nine Months Ended December 31,
(in millions of dollars)	2016		2015
Tobacco purchases	$	9.7	$	19.8
Processing costs	2.7		5.6
Total	$	12.4	$	25.4

The reduced U.S. dollar notional amounts for tobacco purchases and processing costs hedged during the nine months ended December 31, 2016 reflect the reduced size of the 2016 Brazilian crop and a variation in the timing of fixed-price orders from

13

customers for their purchases from the respective crop years. All contracts related to tobacco purchases were designated and qualify as hedges of the future cash flows associated with the forecast purchases of tobacco. As a result, except for amounts related to any ineffective portion of the hedging strategy or any early de-designation of the hedge arrangement, changes in fair values of the forward contracts have been recognized in comprehensive income as they occurred, but only recognized in earnings upon sale of the related tobacco to third-party customers. Forward contracts related to processing costs have not been designated as hedges, and gains and losses on those contracts have been recognized in earnings on a mark-to-market basis.

All forward contracts to hedge purchases of the 2016 crop in Brazil matured and settled by December 31, 2016. For substantially all hedge gains and losses recorded in accumulated other comprehensive loss at December 31, 2016, the Company expects to complete the sale of the tobacco and recognize the amounts in earnings during fiscal year 2017.

Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Net Local Currency Monetary Assets and Liabilities of Foreign Subsidiaries

Most of the Company’s foreign subsidiaries transact the majority of their sales in U.S. dollars and finance the majority of their operating requirements with U.S. dollar borrowings, and therefore use the U.S. dollar as their functional currency. These subsidiaries normally have certain monetary assets and liabilities on their balance sheets that are denominated in the local currency. Those assets and liabilities can include cash and cash equivalents, accounts receivable and accounts payable, advances to farmers and suppliers, deferred income tax assets and liabilities, recoverable value-added taxes, and other items. Net monetary assets and liabilities denominated in the local currency are remeasured into U.S. dollars each reporting period, generating gains and losses that the Company records in earnings as a component of selling, general, and administrative expenses. The level of net monetary assets or liabilities denominated in the local currency normally fluctuates throughout the year based on the operating cycle, but it is most common for monetary assets to exceed monetary liabilities, sometimes by a significant amount. When this situation exists and the local currency weakens against the U.S. dollar, remeasurement losses are generated. Conversely, remeasurement gains are generated on a net monetary asset position when the local currency strengthens against the U.S. dollar. To manage a portion of its exposure to currency remeasurement gains and losses, the Company enters into forward contracts to buy or sell the local currency at future dates coinciding with expected changes in the overall net local currency monetary asset position of the subsidiary. Gains and losses on the forward contracts are recorded in earnings as a component of selling, general, and administrative expenses for each reporting period as they occur, and thus directly offset the related remeasurement losses or gains in the consolidated statements of income for the notional amount hedged. The Company does not designate these contracts as hedges for accounting purposes. The contracts are generally arranged to hedge the subsidiary's projected exposure to currency remeasurement risk for specified periods of time, and new contracts are entered as necessary throughout the year to replace previous contracts as they mature. The Company is currently using forward currency contracts to manage its exposure to currency remeasurement risk in Brazil.  The total notional amounts of contracts outstanding at December 31, 2016 and 2015 were approximately $23.4 million and $56.8 million, respectively. At March 31, 2016, the net local monetary asset position in Brazil was not significant, and there were no foreign currency contracts outstanding at that time to manage currency remeasurement risk. To further mitigate currency remeasurement exposure, the Company’s foreign subsidiaries may utilize short-term local currency financing during certain periods. This strategy, while not involving the use of derivative instruments, is intended to minimize the subsidiary’s net monetary position by financing a portion of the local currency monetary assets with local currency monetary liabilities, thus hedging a portion of the overall position.

Several of the Company’s foreign subsidiaries transact the majority of their sales and finance the majority of their operating requirements in their local currency, and therefore use their respective local currencies as the functional currency for reporting purposes. From time to time, these subsidiaries sell tobacco to customers in transactions that are not denominated in the functional currency. In those situations, the subsidiaries routinely enter into forward exchange contracts to offset currency risk for the period of time that a fixed-price order and the related trade account receivable are outstanding with the customer. The contracts are not designated as hedges for accounting purposes.

14

Effect of Derivative Financial Instruments on the Consolidated Statements of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements of income for the three- and nine-month periods ended December 31, 2016 and 2015:

	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	10,876		$	3,529		$	8,484		$	(2,527	)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	(987	)	$	(1,328	)	$	(3,135	)	$	(4,004	)
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings	$	—		$	—		$	—		$	—
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Floating rate interest payments on term loan
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	—		$	—		$	453		$	1,283
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	102		$	362		$	770		$	720
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings	$	—		$	—		$	246		$	745
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges - Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings	$	(1,576	)	$	(2,366	)	$	(2,932	)	$	6,014
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses

For the interest rate swap agreements, the effective portion of the gain or loss on the derivative is recorded in accumulated other comprehensive loss and any ineffective portion is recorded in selling, general and administrative expenses. For the forward foreign currency exchange contracts designated as cash flow hedges of tobacco purchases in Brazil, a net hedge gain of approximately $0.2 million remained in accumulated other comprehensive loss at December 31, 2016. That balance reflects gains and losses on contracts related to the 2016 crop, less the amount reclassified to earnings related to tobacco sold through December 31, 2016. The majority of the balance in accumulated other comprehensive loss is expected to be recognized in earnings as a component of cost of goods sold in fiscal year 2017 as the 2016 Brazilian crop tobacco is sold to customers. Based on the hedging strategy, as the gain or loss is recognized in earnings, it is expected to be offset by a change in the direct cost for the tobacco or by a change in sales prices if the strategy has been mandated by the customer. Generally, margins on the sale of the tobacco will not be significantly affected.

15

Effect of Derivative Financial Instruments on the Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets at December 31, 2016 and 2015, and March 31, 2016:

	Derivatives in a Fair Value Asset Position							Derivatives in a Fair Value Liability Position
	Balance Sheet Location	Fair Value as of						Balance Sheet Location	Fair Value as of
(in thousands of dollars)		December 31, 2016		December 31, 2015		March 31, 2016			December 31, 2016		December 31, 2015		March 31, 2016
Derivatives Designated as Hedging Instruments
Interest rate swap agreements	Other non-current assets	$	853	$	—	$	—	Other long-term liabilities	$	—	$	1,573	$	10,766
Forward foreign currency exchange contracts	Other current assets	—		—		475		Accounts payable and accrued expenses	—		—		—
Total		$	853	$	—	$	475		$	—	$	1,573	$	10,766
Derivatives Not Designated as Hedging Instruments
Forward foreign currency exchange contracts	Other current assets	$	4	$	540	$	297	Accounts payable and accrued expenses	$	1,229	$	90	$	5
Total		$	4	$	540	$	297		$	1,229	$	90	$	5

Substantially all of the Company's forward foreign exchange contracts are subject to master netting arrangements whereby the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts on a gross basis in the consolidated balance sheets.

NOTE 8.   FAIR VALUE MEASUREMENTS

Universal measures certain financial and nonfinancial assets and liabilities at fair value based on applicable accounting guidance. The financial assets and liabilities measured at fair value include money market funds, trading securities associated with deferred compensation plans, interest rate swap agreements, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers. The application of the fair value guidance to nonfinancial assets and liabilities primarily includes the determination of fair value for goodwill and long-lived assets when indicators of potential impairment are present.

Under the accounting guidance, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The framework for measuring fair value is based on a fair value hierarchy that distinguishes between observable inputs and unobservable inputs. Observable inputs are based on market data obtained from independent sources. Unobservable inputs require the Company to make its own assumptions about the value placed on an asset or liability by market participants because little or no market data exists. There are three levels within the fair value hierarchy:

Level	Description
1	quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the reporting date;
2	quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and
3	unobservable inputs for the asset or liability.

As permitted under the accounting guidance, the Company uses net asset value per share ("NAV") as a practical expedient to measure the fair value of its money market funds. As discussed in Note 2, under updated accounting guidance adopted effective

16

April 1, 2016, the fair values for those funds are no longer categorized within the fair value hierarchy and are presented under the heading "NAV" in the tables that follow in this disclosure.

In measuring the fair value of liabilities, the Company considers the risk of non-performance in determining fair value. Universal has not elected to report at fair value any financial instruments or any other assets or liabilities that are not required to be reported at fair value under current accounting guidance.

At December 31, 2016 and 2015, and at March 31, 2016, the Company had certain financial assets and financial liabilities that were required to be measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified based on how their values were determined under the fair value hierarchy or the NAV practical expedient:

	December 31, 2016
			Fair Value Hierarchy
(in thousands of dollars)	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	241,991	$	—	$	—	$	—	$	241,991
Trading securities associated with deferred compensation plans	—		17,210		—		—		17,210
Interest rate swap agreements	—		—		853		—		853
Forward foreign currency exchange contracts	—		—		4		—		4
Total financial assets measured and reported at fair value	$	241,991	$	17,210	$	857	$	—	$	260,058
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,844	$	1,844
Forward foreign currency exchange contracts	—		—		1,229		—		1,229
Total financial liabilities measured and reported at fair value	$	—	$	—	$	1,229	$	1,844	$	3,073

	December 31, 2015
			Fair Value Hierarchy
(in thousands of dollars)	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	26,578	$	—	$	—	$	—	$	26,578
Trading securities associated with deferred compensation plans	—		18,907		—		—		18,907
Forward foreign currency exchange contracts	—		—		540		—		540
Total financial assets measured and reported at fair value	$	26,578	$	18,907	$	540	$	—	$	46,025
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,469	$	1,469
Interest rate swap agreements	—		—		1,573		—		1,573
Forward foreign currency exchange contracts	—		—		90		—		90
Total financial liabilities measured and reported at fair value	$	—	$	—	$	1,663	$	1,469	$	3,132

17

	March 31, 2016
			Fair Value Hierarchy
(in thousands of dollars)	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	116,618	$	—	$	—	$	—	$	116,618
Trading securities associated with deferred compensation plans	—		17,817		—		—		17,817
Forward foreign currency exchange contracts	—		—		772		—		772
Total financial assets measured and reported at fair value	$	116,618	$	17,817	$	772	$	—	$	135,207
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,628	$	1,628
Interest rate swap agreements	—		—		10,766		—		10,766
Forward foreign currency exchange contracts	—		—		5		—		5
Total financial liabilities measured and reported at fair value	$	—	$	—	$	10,771	$	1,628	$	12,399

Money market funds

The fair value of money market funds, which are reported in cash and cash equivalents in the consolidated balance sheets, is based on NAV, which is the amount at which the funds are redeemable and is used as a practical expedient for fair value. These funds are not classified in the fair value hierarchy, but are disclosed as part of the fair value table above.

Trading securities associated with deferred compensation plans

Trading securities represent mutual fund investments that are matched to employee deferred compensation obligations. These investments are bought and sold as employees defer compensation, receive distributions, or make changes in the funds underlying their accounts. Quoted market prices (Level 1) are used to determine the fair values of the mutual funds.

Interest rate swap agreements

The fair values of interest rate swap agreements are determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, interest rate swaps are classified within Level 2 of the fair value hierarchy.

Forward foreign currency exchange contracts

The fair values of forward foreign currency exchange contracts are also determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, forward foreign currency exchange contracts are classified within Level 2 of the fair value hierarchy.

Guarantees of bank loans to tobacco growers

The Company guarantees bank loans to tobacco growers in Brazil for crop financing. In the event that the farmers default on their payments to the banks, the Company would be required to perform under the guarantees. The Company regularly evaluates the likelihood of farmer defaults based on an expected loss analysis and records the fair value of its guarantees as an obligation in its consolidated financial statements. The fair value of the guarantees is determined using the expected loss data for all loans outstanding at each measurement date. The present value of the cash flows associated with the estimated losses is then calculated at a risk-adjusted interest rate that is aligned with the expected duration of the liability and includes an adjustment for nonperformance risk. This approach is sometimes referred to as the “contingent claims valuation method.” Although historical loss data is an observable input, significant judgment is required in applying this information to the portfolio of guaranteed loans outstanding at each measurement date and in selecting a risk-adjusted interest rate. Significant increases or decreases in the risk-adjusted interest rate may result in a significantly higher or lower fair value measurement. The guarantees of bank loans to tobacco growers are therefore classified within Level 3 of the fair value hierarchy.

18

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 3) for the nine months ended December 31, 2016 and 2015 is provided below.

	Nine Months Ended December 31,
(in thousands of dollars)	2016			2015
Balance at beginning of year	$	1,628		$	1,674
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from portfolio)	(1,848		)	(1,826		)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,856			1,851
Change in discount rate and estimated collection period	55			76
Currency remeasurement	153			(306		)
Balance at end of period	$	1,844		$	1,469

Long-term Debt

The fair value of the Company’s long-term debt, including the current portion, was approximately $370 million at each of the balance sheet dates December 31, 2016, December 31, 2015, and March 31, 2016. The Company estimates the fair value of its long-term debt using Level 2 inputs which are based upon quoted market prices for the same or similar issues or on the current interest rates available to the Company for debt of similar terms and maturities.

NOTE 9.   PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

The Company sponsors several defined benefit pension plans covering U.S. salaried employees and certain foreign and other employee groups. These plans provide retirement benefits based primarily on employee compensation and years of service. The Company also sponsors defined benefit plans that provide postretirement health and life insurance benefits for eligible U.S. employees attaining specific age and service levels.

The components of the Company’s net periodic benefit cost were as follows:

	Pension Benefits						Other Postretirement Benefits
	Three Months Ended December 31,						Three Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
Service cost	$	1,343		$	1,469		$	73		$	106
Interest cost	2,453			2,345			378			387
Expected return on plan assets	(3,584		)	(3,574		)	(11		)	(15		)
Net amortization and deferral	843			1,201			(100		)	(44		)
Net periodic benefit cost	$	1,055		$	1,441		$	340		$	434

	Pension Benefits						Other Postretirement Benefits
	Nine Months Ended December 31,						Nine Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
Service cost	$	4,063		$	4,431		$	220		$	320
Interest cost	7,389			7,038			1,136			1,186
Expected return on plan assets	(10,762		)	(10,727		)	(33		)	(45		)
Net amortization and deferral	2,519			3,599			(300		)	(132		)
Net periodic benefit cost	$	3,209		$	4,341		$	1,023		$	1,329

19

The net periodic benefit cost for the Company's pension and other postretirement benefit plans has declined from the prior fiscal year, primarily reflecting actuarial gains from higher market discount rates applicable to the most recent actuarial measurement of benefit liabilities.

During the nine months ended December 31, 2016, the Company made contributions of approximately $10.4 million to its pension plans. Additional contributions of approximately $0.6 million are expected during the remaining three months of fiscal year 2017.

20

NOTE 10.   STOCK-BASED COMPENSATION

Universal’s shareholders have approved Executive Stock Plans (“Plans”) under which officers, directors, and employees of the Company may receive grants and awards of common stock, restricted stock, restricted stock units (“RSUs”), performance share awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options. The Company’s practice is to award grants of stock-based compensation to officers on an annual basis at the first regularly-scheduled meeting of the Executive Compensation, Nominating and Corporate Governance Committee of the Board of Directors (the “Compensation Committee”) in the fiscal year following the public release of the Company’s financial results for the prior year. The Compensation Committee administers the Company’s Plans consistently, following previously defined guidelines. Awards of restricted stock, RSUs, PSAs, and SARs are currently outstanding under the Plans. The SARs have an exercise price equal to the closing price of a share of the Company's common stock on the grant date. They are settled in shares of common stock, vest in equal one-third tranches one, two, and three years after the grant date, and expire on the earlier of three years after the grantee’s retirement date or ten years after the grant date. The Company has not made grants of SARs since fiscal year 2012. The RSUs vest five years from the grant date and are then paid out in shares of common stock. Under the terms of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the same date as the original RSU grant. The PSAs vest at the end of a three years performance period that begins with the year of the grant, are paid out in shares of common stock shortly after the vesting date, and do not carry rights to dividends or dividend equivalents prior to vesting. Shares ultimately paid out under PSA grants are dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range from zero to 150% of the stated award. The Company’s outside directors automatically receive restricted stock units or shares of restricted stock following each annual meeting of shareholders. RSUs awarded to outside directors vest three years after the grant date, and restricted shares vest upon the individual’s retirement from service as a director.

As discussed in Note 2, effective April 1, 2016, the Company early adopted recently-issued updates to the accounting guidance for stock-based compensation. Those updates primarily related to the income tax consequences of stock-based payment transactions, the treatment of excess tax benefits in determining income tax expense, the classification of awards as either equity or liabilities, and the classification of transactions in the statement of cash flows.

During the nine-month periods ended December 31, 2016 and 2015, Universal issued the following stock-based awards, representing the regular annual grants to officers and outside directors of the Company:

	Nine Months Ended December 31,
	2016		2015
RSUs:
Number granted	63,425		67,750
Grant date fair value	$	55.93	$	52.10
PSAs:
Number granted	54,675		57,750
Grant date fair value	$	49.17	$	45.06

As indicated in the table above, the Compensation Committee awarded only grants of RSUs and PSAs in both the current and prior fiscal years, and did not award any other types of stock-based compensation.

Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of: (1) the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award. For employees who are already eligible to retire at the date an award is granted, the total fair value of all non-forfeitable awards is recognized as expense at the date of grant. As a result, Universal typically incurs higher stock compensation expense in the first quarter of each fiscal year when grants are awarded to officers than in the other three quarters. For PSAs, the Company generally recognizes fair value expense ratably over the performance and vesting period based on management’s judgment of the ultimate award that is likely to be paid out based on the achievement of the predetermined performance measures. The Company accounts for forfeitures of stock-based awards as they occur. For the nine-month periods ended December 31, 2016 and 2015, the Company recorded total stock-based compensation expense of approximately $4.8 million and $4.2 million, respectively. The Company expects to recognize stock-based compensation expense of approximately $1.1 million during the remaining three months of fiscal year 2017.

21

NOTE 11. OPERATING SEGMENTS

The principal approach used by management to evaluate the Company’s performance is by geographic region, although the dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations. The Company evaluates the performance of its segments based on operating income after allocated overhead expenses (excluding significant non-recurring charges or credits), plus equity in the pretax earnings of unconsolidated affiliates.

Operating results for the Company’s reportable segments for each period presented in the consolidated statements of income and comprehensive income were as follows:

	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
SALES AND OTHER OPERATING REVENUES
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	93,198		$	81,463		$	246,669		$	179,456
Other Regions (1)	495,982			460,729			992,574			1,009,162
Subtotal	589,180			542,192			1,239,243			1,188,618
Other Tobacco Operations (2)	79,591			42,400			181,945			127,775
Consolidated sales and other operating revenues	$	668,771		$	584,592		$	1,421,188		$	1,316,393
OPERATING INCOME
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	1,025		$	5,750		$	21,404		$	12,949
Other Regions (1)	81,074			61,318			96,399			87,673
Subtotal	82,099			67,068			117,803			100,622
Other Tobacco Operations (2)	5,781			1,083			10,215			2,136
Segment operating income	87,880			68,151			128,018			102,758
Deduct: Equity in pretax earnings of unconsolidated affiliates (3)	(4,495		)	(2,326		)	(5,625		)	(2,556		)
Restructuring and impairment costs (4)	(178		)	—			(3,860		)	(2,389		)
Add: Other income (5)	—			3,390			—			3,390
Consolidated operating income	$	83,207		$	69,215		$	118,533		$	101,203

⁽¹⁾  Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

⁽²⁾  Includes Dark Air-Cured, Special Services, and Oriental, as well as inter-company eliminations. Sales and other operating revenues for this reportable segment include limited amounts for Oriental because its financial results consist principally of equity in the pretax earnings of an unconsolidated affiliate.

⁽³⁾  Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

⁽⁴⁾  Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

⁽⁵⁾  Other income represents a gain from remeasuring to fair value the Company's original 50% ownership interest in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner. This item is excluded from segment operating income, but is included in consolidated operating income in the consolidated statements of income and comprehensive income.

22

NOTE 12. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in the accumulated balances for each component of accumulated other comprehensive income (loss) attributable to the Company for the nine months ended December 31, 2016 and 2015:

	Nine Months Ended December 31,
(in thousands of dollars)	2016			2015
Foreign currency translation:
Balance at beginning of year	$	(26,992	)	$	(31,138	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax benefit of $4,408 and $319)	(8,186		)	(508		)
Less: Net loss on foreign currency translation attributable to noncontrolling interests	645			465
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(7,541		)	(43		)
Balance at end of period	$	(34,533	)	$	(31,181	)
Foreign currency hedge:
Balance at beginning of year	$	675		$	(1,834	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $1,006 and $(464))	(1,868		)	861
Reclassification of (gain) loss to earnings (net of tax benefit of $(304) and $(188))(1)	564			352
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(1,304		)	1,213
Balance at end of period	$	(629	)	$	(621	)
Interest rate hedge:
Balance at beginning of year	$	(6,997	)	$	(1,982	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(2,969) and $885)	5,514			(1,643		)
Reclassification of loss to earnings (net of tax benefit of $(1,098) and $(1,402))(2)	2,038			2,603
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	7,552			960
Balance at end of period	$	555		$	(1,022	)
Pension and other postretirement benefit plans:
Balance at beginning of year	$	(39,036	)	$	(40,040	)
Other comprehensive income (loss) attributable to Universal Corporation:
Amortization included in earnings (net of tax benefit of $(881) and $(1,257)) (3)	1,920			2,425
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,920			2,425
Balance at end of period	$	(37,116	)	$	(37,615	)
Total accumulated other comprehensive loss at end of period	$	(71,723	)	$	(70,439	)

⁽¹⁾ Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 7 for additional information.

⁽²⁾   Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the underlying debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 7 for additional information.

⁽³⁾ This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 9 for additional information.

23

NOTE 13. CHANGES IN SHAREHOLDERS' EQUITY AND NONCONTROLLING INTERESTS IN SUBSIDIARIES

A reconciliation of the changes in Universal Corporation shareholders’ equity and noncontrolling interests in subsidiaries for the nine months ended December 31, 2016 and 2015 is as follows:

	Nine Months Ended December 31, 2016									Nine Months Ended December 31, 2015
(in thousands of dollars)	Universal Corporation			Non-controlling Interests			Total			Universal Corporation			Non-controlling Interests			Total
Balance at beginning of year	$	1,414,222		$	38,840		$	1,453,062		$	1,362,725		$	34,369		$	1,397,094
Changes in preferred stock
Conversion of Series B 6.75% convertible perpetual preferred stock to common stock	(107,550		)	—			(107,550		)	—			—			—
Changes in common stock
Conversion of Series B 6.75% convertible perpetual preferred stock to common stock	107,550			—			107,550			—			—			—
Accrual of stock-based compensation	4,766			—			4,766			4,157			—			4,157
Withholding of shares from stock-based compensation for grantee income taxes	(2,256		)	—			(2,256		)	(3,737		)	—			(3,737		)
Dividend equivalents on RSUs	503			—			503			519			—			519
Changes in retained earnings
Net income	73,435			2,621			76,056			61,052			4,502			65,554
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock	(11,061		)	—			(11,061		)	(11,061		)	—			(11,061		)
Common stock	(37,787		)	—			(37,787		)	(35,641		)	—			(35,641		)
Dividend equivalents on RSUs	(503		)	—			(503		)	(519		)	—			(519		)
Other comprehensive income (loss)	627			(645		)	(18		)	4,555			(465		)	4,090
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders	—			(1,260		)	(1,260		)	—			(1,260		)	(1,260		)
Balance at end of period	$	1,441,946		$	39,556		$	1,481,502		$	1,382,050		$	37,146		$	1,419,196

24

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q and the following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Among other things, these statements relate to the Company’s financial condition, results of operation, and future business plans, operations, opportunities, and prospects. In addition, the Company and its representatives may from time to time make written or oral forward-looking statements, including statements contained in other filings with the Securities and Exchange Commission and in reports to shareholders. These forward-looking statements are generally identified by the use of words such as we “expect,” “believe,” “anticipate,” “could,” “should,” “may,” “plan,” “will,” “predict,” “estimate,” and similar expressions or words of similar import. These forward-looking statements are based upon management’s current knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, anticipated levels of demand for and supply of our products and services; costs incurred in providing these products and services; timing of shipments to customers; changes in market structure; government regulation; product taxation; industry consolidation and evolution; changes in exchange rates and interest rates; regulation and litigation impacts on our customers; and general economic, political, market, and weather conditions. For a further description of factors that may cause actual results to differ materially from such forward-looking statements, see Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2016. We caution investors not to place undue reliance on any forward-looking statements as these statements speak only as of the date when made, and we undertake no obligation to update any forward-looking statements made in this report. This Form 10-Q should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended March 31, 2016.

Liquidity and Capital Resources

Overview

After significant seasonal working capital investment in the first half of the fiscal year, we generally see inventory levels and other working capital items decrease in the second half of our fiscal year as crops in Africa, South America, and North America are being shipped. Our buying program in Brazil was reduced this fiscal year due to the smaller size of the Brazilian crop, largely due to El Nino weather patterns, and unsustainable green leaf prices. These lower Brazilian crop purchase volumes significantly reduced our working capital requirements there. Although December 31, 2016 working capital levels remained above September 30, 2016 levels, we saw the beginning of the seasonal contraction in our working capital by the end of the third fiscal quarter. Tobacco inventory levels declined, cash flow generated by operations increased, and cash balances increased in the three months ended December 31, 2016. We funded our working capital needs for the nine months ended December 31, 2016, using a combination of cash on hand, short-term borrowings, customer advances, and operating cash flows. Similar to the prior fiscal year, we expect shipments to be heavily weighted to the second half of the fiscal year.

Our liquidity and capital resource requirements are predominantly short term in nature and relate to working capital for tobacco crop purchases. Working capital needs are seasonal within each geographic region. The geographic dispersion and the timing of working capital needs permit us to predict our general level of cash requirements, although crop size, prices paid to farmers, shipment and delivery timing, and currency fluctuations affect requirements each year. Peak working capital requirements are generally reached during the first and second fiscal quarters. Each geographic area follows a cycle of buying, processing, and shipping, and in many regions, we also provide agricultural materials to farmers during the growing season. The timing of the elements of each cycle is influenced by such factors as local weather conditions and individual customer shipping requirements, which may change the level or the duration of crop financing. Despite a predominance of short-term needs, we maintain a portion of our total debt as long-term to reduce liquidity risk. We also periodically have large cash balances that we utilize to meet our working capital requirements.

Operating Activities

Our operations generated $182.8 million in net cash flows during the nine months ended December 31, 2016. That amount was $172.6 million higher than during the same period last fiscal year, largely due to lower working capital requirements in the nine months ended December 31, 2016, on the reduced purchase volumes in Brazil, as well as earlier shipment timing in some origins this year. Tobacco inventory increased by $99.2 million from March 31, 2016 levels to $736.4 million at December 31, 2016, primarily on seasonal leaf purchases. Tobacco inventory levels were $229.5 million below December 31, 2015 levels, largely due to the lower purchase volumes in Brazil and earlier shipment timing this year. Inventory is usually financed with a mix of cash, notes payable, and customer deposits, depending on our available cash balances, borrowing capabilities, interest rates, and exchange rates, as well as those of our customers. We generally do not purchase material quantities of tobacco on a speculative basis. However, when we

25

contract directly with farmers, we are often obligated to buy all stalk positions, which may contain less marketable leaf styles. At December 31, 2016, our uncommitted inventories were $124.2 million, or about 17% of total tobacco inventory, compared to $120.8 million, or about 19% of our March 31, 2016 inventory, and $132.4 million, or about 14% of our December 31, 2015 inventory. The level of these uncommitted inventory percentages is influenced by timing of farmer deliveries of new crops, as well as the timing of customer orders and shipments.

Our balance sheet accounts reflected seasonal patterns in the nine months ended December 31, 2016, on deliveries of crops by farmers in South America, Africa, and North America. Accounts receivable decreased by $147.7 million from March 31, 2016 levels, reflecting collections on receivables. Due primarily to lower crop purchases in fiscal year 2017 in Brazil, earlier shipment timing in some origins, and higher cash balances at March 31, 2016, our cash and cash equivalent balances were $243.9 million higher at December 31, 2016, compared to December 31, 2015 balances. Customer advances and deposits decreased by $27.0 million compared to the same period in the prior fiscal year, largely on earlier shipments in some origins.

Investing Activities

Our capital expenditures are generally limited to those that add value, replace or maintain equipment, increase efficiency, or position us for future growth. In deciding where to invest capital resources, we look for opportunities where we believe we can earn an adequate return, leverage our assets and expertise, and enhance our farmer base. During the nine months ended December 31, 2016 and 2015, we invested about $28.5 million and $38.5 million, respectively, in our property, plant and equipment. Depreciation expense was approximately $26.1 million and $27.2 million for the nine months ended December 31, 2016 and 2015, respectively. Generally, our routine capital spending is at a level below depreciation expense in order to maintain strong cash flow. However, from time to time, we undertake projects that increase capital spending beyond those limits when we identify opportunities to improve efficiencies, add value for our customers, and position us for future growth. We currently plan to spend approximately $40 to $45 million over the next twelve months on capital projects for maintenance of our facilities and other investments to grow and improve our businesses.

Financing Activities

We consider the sum of notes payable and overdrafts, long-term debt (including any current portion), and customer advances and deposits, less cash, cash equivalents, and short-term investments on our balance sheet to be our net debt. We also consider our net debt plus shareholders' equity to be our net capitalization. Net debt decreased by about $108.1 million to $23.4 million during the nine months ended December 31, 2016. The decrease primarily reflects higher cash balances. Net debt as a percentage of net capitalization of approximately 2% at December 31, 2016, was down from the December 31, 2015 level of approximately 18% and from approximately 8% at March 31, 2016. We entered fiscal year 2017 with cash and cash equivalent balances that were $70.7 million higher than the prior fiscal year, and our working capital requirements are lower this fiscal year because of our reduced buying program in Brazil, which reduced our short-term borrowing requirements in the nine months ended December 31, 2016. Earlier shipment timing in some origins also increased our cash balances. As of December 31, 2016, we had $411.5 million in cash and cash equivalents, our short-term debt totaled $52.1 million, and we were in compliance with all covenants of our debt agreements, which require us to maintain certain levels of tangible net worth and observe restrictions on debt levels.

As of December 31, 2016, we had $430 million available under a committed revolving credit facility that will mature in December 2019, and we had about $320 million in unused, uncommitted credit lines. We also maintain an effective, undenominated universal shelf registration that provides for future issuance of additional debt or equity securities. We have no long-term debt maturing in fiscal years 2017 or 2018. Our seasonal working capital requirements typically increase significantly between March and September and decline after mid-year. Available capital resources from our cash balances, committed credit facility, and uncommitted credit lines exceed our normal working capital needs and currently anticipated capital expenditure requirements over the next twelve months.

During December 2016, holders of 111,072 shares of our Series B 6.75% Convertible Perpetual Preferred Stock (“Series B Preferred Stock”) voluntarily exercised their conversion rights. These shares of Series B Preferred Stock were converted into 2,487,118 shares of our common stock. In January 2017, we exercised our option to mandatorily convert all remaining outstanding shares of our Series B Preferred Stock and elected to settle our conversion obligation in cash. Holders of the Series B Preferred Stock received the product of the conversion rate, 22.4306, and the average volume weighted average price of our common stock during the cash settlement averaging period for each share of Series B Preferred Stock converted. The cash settlement occurred on January 31, 2017, and totaled approximately $178 million on the 107,418 shares of Series B Preferred Stock converted. We used cash on hand for the settlement. All rights of the holders with respect to the Series B Preferred Stock terminated upon conversion. We will no longer be required to pay the Series B Preferred Stock dividends which totaled approximately $15 million per annum.

26

Our Board of Directors approved our current share repurchase program in November 2015. The program expires in November 2017 and authorizes the purchase of up to $100 million of our common and preferred stock. Under the current authorization, we may purchase shares from time to time on the open market or in privately negotiated transactions at prices not exceeding prevailing market rates. In determining our level of share repurchase activity, our intent is to use only cash available after meeting our anticipated capital investment, dividend, and working capital requirements. Repurchases of shares under the repurchase program may vary based on management discretion, as well as changes in cash flow generation and availability. During the nine months ended December 31, 2016, we did not purchase any shares of our common or preferred stock. As of December 31, 2016, approximately 25.3 million shares of our common stock were outstanding, and our available authorization under our current share repurchase program was $100 million. The previously discussed Series B Preferred Stock conversion did not affect availability under this program. As of January 13, 2017, no shares of our preferred stock were outstanding.

Derivatives

From time to time, we use interest rate swap agreements to manage our exposure to changes in interest rates. At December 31, 2016, the fair value of our outstanding interest rate swap agreements was an asset of about $0.9 million, and the notional amount swapped was $370 million. We entered into these agreements to eliminate the variability of cash flows in the interest payments on our variable-rate term loans. Under the swap agreements we receive variable rate interest and pay fixed rate interest. The swaps are accounted for as cash flow hedges.

We also enter forward contracts from time to time to hedge certain foreign currency exposures, primarily related to forecast purchases of tobacco and related processing costs in Brazil, as well as our net monetary asset exposure in local currency there. We generally account for our hedges of forecast tobacco purchases as cash flow hedges. At December 31, 2016, we had no open hedge contracts for those purposes. We had forward contracts outstanding that were not designated as hedges, and the fair value of those contracts was a net liability of about $1.2 million at December 31, 2016.

Results of Operations

Amounts described as net income (loss) and earnings (loss) per diluted share in the following discussion are attributable to Universal Corporation and exclude earnings related to non-controlling interests in subsidiaries. The total for segment operating income (loss) referred to in the discussion below is a non-GAAP financial measure. This measure is not a financial measure calculated in accordance with GAAP and should not be considered as a substitute for net income (loss), operating income (loss), cash from operating activities or any other operating performance measure calculated in accordance with GAAP, and it may not be comparable to similarly titled measures reported by other companies. We have provided a reconciliation of the total for segment operating income (loss) to consolidated operating income (loss) in Note 11. "Operating Segments" to the consolidated financial statements in Item 1. We evaluate our segment performance excluding certain significant charges or credits. We believe this measure, which excludes these items that we believe are not indicative of our core operating results, provides investors with important information that is useful in understanding our business results and trends.

Net income for the nine months ended December 31, 2016, was $73.4 million, or $2.63 per diluted share, compared with $61.1 million, or $2.18 per diluted share for the same period last year.  Operating income for the nine months ended December 31, 2016, of $118.5 million increased by $17.3 million compared to the nine months ended December 31, 2015.  For the third fiscal quarter ended December 31, 2016, net income was $53.6 million, or $1.92 per diluted share, compared with net income for the prior year’s third quarter of $44.5 million, or $1.60 per diluted share. Operating income for the quarter ended December 31, 2016, increased by $14.0 million to $83.2 million compared to the three months ended December 31, 2015. Segment operating income for the nine months ended December 31, 2016, was $128.0 million, an increase of $25.3 million, and for the quarter ended December 31, 2016, was $87.9 million, an increase of $19.7 million, both compared to the same periods last fiscal year.  Those increases resulted from earnings improvements in all segments in the nine months ended December 31, 2016, and in the Other Regions and the Other Tobacco Operations segments, offset in part by a decline in the North America segment, in the three months ended December 31, 2016. Consolidated revenues increased by $104.8 million to $1.4 billion for the nine months ended December 31, 2016, and by $84.2 million to $668.8 million for the three months ended December 31, 2016, compared to the same periods in the prior year, mostly as a result of higher volumes.

Flue-cured and Burley Leaf Tobacco Operations

Other Regions

The Other Regions segment operating income increased by $8.7 million to $96.4 million for the nine months, and by $19.8 million to $81.1 million for the quarter ended December 31, 2016, compared to the same periods in the prior fiscal year.  Both periods

27

benefited from strong third quarter results, including higher sales volumes, lower selling, general, and administrative expenses, and the receipt of distributions from unconsolidated subsidiaries received during the second fiscal quarter in the prior year. The third quarter volume increases were mainly driven by the Africa region, with higher shipments due in part to earlier shipment timing this year. Those volume improvements were partly offset by declines in South America, on lower volumes and higher factory unit costs as a result of the reduced buying program and fewer third-party processing volumes there this year. Asia results were down for the nine months on lower current crop sales despite stronger third quarter volumes. Selling, general, and administrative costs for the nine months ended December 31, 2016, were significantly lower, primarily from the reversal of value-added tax reserves, and favorable comparison to costs incurred in fiscal year 2016 to settle third party challenges to the property rights and valuation of land. Selling, general, and administrative expenses decreased slightly for the third fiscal quarter compared to the prior year from recoveries on customer receivables, partially offset by higher currency remeasurement and exchange losses. Revenues for the Other Regions segment for the nine months ended December 31, 2016, were down by $16.6 million to $992.6 million compared to the same period last year, as slightly higher volumes were more than offset by lower green prices and reduced processing revenue. For the third quarter of fiscal year 2017, revenues increased by $35.3 million to $496.0 million driven by the higher sales volumes, offset in part by lower overall green leaf prices, as well as the receipt of distributions from unconsolidated subsidiaries.

North America

North America segment operating income of $21.4 million for the nine months ended December 31, 2016, increased by $8.5 million, compared with the same period in the previous year, reflecting higher volumes. Segment operating income of $1.0 million for the third fiscal quarter of 2017 declined by $4.7 million compared with the prior year. Despite higher volumes, results for the quarter were hampered by reduced factory yields and inventory writedowns from weather-affected U.S. crops, a less favorable product mix, as well as negative comparisons from the timing of export sales in Guatemala and Mexico, which fell into the second fiscal quarter this year. Selling, general and administrative costs were relatively flat for both the three- and nine-month comparative periods. Segment revenues increased by $67.2 million to $246.7 million for the nine months and by $11.7 million to $93.2 million for the third quarter of fiscal year 2017, compared with the same periods in fiscal year 2016, on those higher volumes, partly offset by lower average green leaf prices and a less favorable product mix.

Other Tobacco Operations

The Other Tobacco Operations segment’s operating income increased by $8.1 million to $10.2 million for the nine months and by $4.7 million to $5.8 million for the third fiscal quarter ended December 31, 2016, compared with the same periods last fiscal year. In both periods, earnings improved for the dark tobacco operations on higher volumes, due in part to recovery in Indonesia where certain crops had been damaged by volcanic ash last year. Earnings for the oriental joint venture increased on a better sales mix for the nine months and higher volumes from some earlier shipment timing for the third fiscal quarter, as well as favorable comparisons to tax accruals in the prior year for both periods. For the nine months ended December 31, 2016, the special services group saw higher losses primarily for the new food ingredients business, compared with the prior year. Selling, general, and administrative costs for the segment were relatively flat for both the nine months and third fiscal quarter of the current year compared with the previous year. Revenues for the Other Tobacco Operations segment were up by $54.2 million to $181.9 million for the nine months, and by $37.2 million to $79.6 million for the third fiscal quarter ended December 31, 2016, mostly due to increased volumes and the timing of shipments of oriental tobaccos into the United States, as well as the higher volumes for the dark tobacco operations, compared to the same periods in the prior year.

Other Items

Cost of goods sold increased by about 9% to $1.1 billion for the nine months ended December 31, 2016, and by about 15% to $533.3 million for the third quarter of fiscal year 2017 compared with the same periods in fiscal year 2016. For both periods, the increase reflected higher leaf sales volumes. Selling, general, and administrative costs declined by $13.1 million in the nine months ended December 31, 2016, and by $2.0 million for the third fiscal quarter compared with the same periods in the prior fiscal year. In the nine months ended December 31, 2016, benefits were achieved from a combination of items, including a favorable comparison to costs incurred in the second quarter of fiscal year 2016 to settle third party challenges to the property rights and valuation of a large tract of forestry land, and the reversal in the second quarter of fiscal year 2017 of value-added tax reserves. In the third fiscal quarter of 2017, selling, general, and administrative expenses decreased on recoveries on customer receivables and lower compensation costs, partially offset by higher currency remeasurement and exchange losses, mainly in Africa and Europe.

The consolidated effective income tax rates were approximately 32% and 33% for the quarter and nine months ended December 31, 2016, respectively, and for the quarter and nine-month periods ended December 31, 2015, were approximately 32% and 29%, respectively.   Income taxes for those periods in both fiscal years were lower than the 35% federal statutory rate on a

28

combination of lower net effective tax rates on income from certain foreign subsidiaries, and effects of changes in local currency exchange rates on deferred income tax balances.

Results for the nine months and third fiscal quarter ended December 31, 2016 included restructuring and impairment costs of $3.9 million ($0.09 per diluted share) and  $0.2 million ($0.00 per diluted share), respectively. Results for the nine months ended December 31, 2015, included restructuring and impairment costs of $2.4 million ($0.07 per diluted share) and a gain of $3.4 million on remeasuring the Company’s interest in a tobacco processing joint venture to fair value upon acquiring our partner’s 50% ownership in the third fiscal quarter ($0.10 for the nine months and $0.08 for the quarter per diluted share).

General Overview

We are pleased with the performance of our operations thus far this fiscal year, particularly in light of difficult supply conditions, including the weather-related crop reduction in Brazil. Despite these headwinds, we have been able to secure some additional sales which have helped to increase our volumes handled so far this fiscal year. In addition, our third fiscal quarter this year benefited from higher volumes mainly due to earlier shipping patterns than those of the prior year. We expect our volumes for the fourth quarter of fiscal year 2017 to be lower than those achieved in the fourth quarter of the prior year, given our reduced buying program in Brazil this fiscal year, and some earlier shipments from other origins. Last fiscal year’s fourth quarter volumes were exceptionally strong for us and included significant volumes from Brazil. However, we now believe our total lamina volumes for fiscal year 2017 will be only modestly lower than those volumes in fiscal year 2016.

Our cash flows from operations were strong for the nine months ended December 31, 2016, largely due to our reduced working capital requirements this fiscal year on fewer purchases in Brazil and earlier shipment timing in some origins. As a result, our cash balances have increased, and our seasonal borrowing requirements have decreased this fiscal year. In addition, our uncommitted inventory levels at December 31, 2016, remain within our target range and are approximately $8 million below our December 31, 2015 levels.

We continue to work to deliver value to our shareholders and maintain our strong capital structure, which had included 6.75% convertible preferred stock requiring dividend payments of about $15 million per annum. In December 2016, we received voluntary conversion requests for about half of the outstanding shares of preferred stock. We settled those requests by issuing approximately 2.5 million shares of common stock, which will be eligible for common dividends, for those shares of preferred stock . Subsequently, in our fourth fiscal quarter, we elected to exercise a mandatory conversion of the remaining outstanding shares of our preferred stock. This mandatory conversion was settled in cash rather than shares of common stock at a cost of approximately $178 million on January 31, 2017. By using cash on hand for the mandatory conversion instead of issuing shares of common stock, we believe that we increased the value of common shareholders’ investment in our Company while maintaining the strength of our balance sheet.

29

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Currency

The international leaf tobacco trade generally is conducted in U.S. dollars, thereby limiting foreign exchange risk to that which is related to leaf purchase and production costs, overhead, and income taxes in the source country. We also provide farmer advances that are directly related to leaf purchases and are denominated in the local currency. Any currency gains or losses on those advances are usually offset by decreases or increases in the cost of tobacco, which is priced in the local currency. However, the effect of the offset may not occur until a subsequent quarter or fiscal year. Most of our tobacco operations are accounted for using the U.S. dollar as the functional currency. Because there are no forward foreign exchange markets in many of our major countries of tobacco origin, we often manage our foreign exchange risk by matching funding for inventory purchases with the currency of sale, which is usually the U.S. dollar, and by minimizing our net local currency monetary position in individual countries. We are vulnerable to currency remeasurement gains and losses to the extent that monetary assets and liabilities denominated in local currency do not offset each other. In addition to foreign exchange gains and losses, we are exposed to changes in the cost of tobacco due to changes in the value of the local currency in relation to the U.S. dollar. We routinely enter forward currency exchange contracts to hedge against the effects of currency movements on purchases of tobacco to reduce the volatility of costs. In addition, from time-to-time we enter forward contracts to hedge balance sheet exposures.

In certain tobacco markets that are primarily domestic, we use the local currency as the functional currency. Examples of these markets are Hungary, Poland, and the Philippines. In other markets, such as Western Europe, where export sales have been primarily in local currencies, we also use the local currency as the functional currency. In each case, reported earnings are affected by the translation of the local currency into the U.S. dollar.

Interest Rates

We generally use both fixed and floating interest rate debt to finance our operations. Changes in market interest rates expose us to changes in cash flows for floating rate instruments and to changes in fair value for fixed-rate instruments. We normally maintain a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge agreements to swap the interest rates. In addition, our customers may pay market rates of interest for inventory purchased on order, which could mitigate a portion of the floating interest rate exposure. We also periodically have large cash balances and may receive deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs. Excluding our bank term loans which were converted to fixed-rate borrowings with interest rate swaps in January 2015, debt carried at variable interest rates was approximately $52 million at December 31, 2016. Although a hypothetical 1% change in short-term interest rates would result in a change in annual interest expense of approximately $0.5 million, that amount would be at least partially mitigated by changes in charges to customers.

Derivatives Policies

Hedging interest rate exposure using swaps and hedging foreign exchange exposure using forward contracts are specifically contemplated to manage risk in keeping with management's policies. We may use derivative instruments, such as swaps, forwards, or futures, which are based directly or indirectly upon interest rates and currencies to manage and reduce the risks inherent in interest rate and currency fluctuations. When we use foreign currency derivatives to mitigate our exposure to exchange rate fluctuations, we may choose not to designate them as hedges for accounting purposes, which may result in the effects of the derivatives being recognized in our earnings in periods different from the items that created the exposure.

We do not utilize derivatives for speculative purposes, and we do not enter into market risk-sensitive instruments for trading purposes. Derivatives are transaction specific so that a specific debt instrument, forecast purchase, contract, or invoice determines the amount, maturity, and other specifics of the hedge. We routinely review counterparty risk as part of our derivative program.

30

ITEM 4. CONTROLS AND PROCEDURES

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in reports we file under the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer (Principal Executive Officer and Principal Financial Officer), as appropriate, to allow for timely decisions regarding required disclosure. Our Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) evaluated, with the participation of other members of management, the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, management concluded that our disclosure controls and procedures were effective. There were no changes in our internal controls over financial reporting identified in connection with this evaluation that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

31

PART II. OTHER INFORMATION

ITEM 1.   LEGAL PROCEEDINGS

Some of our subsidiaries are involved in litigation or legal matters incidental to their business activities.  While the outcome of these matters cannot be predicted with certainty, we are vigorously defending them and do not currently expect that any of them will have a material adverse effect on our business or financial position. However, should one or more of these matters be resolved in a manner adverse to our current expectation, the effect on our results of operations for a particular fiscal reporting period could be material.

ITEM 1A. RISK FACTORS

As of the date of this report, there are no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended March 31, 2016 (the "2016 Annual Report on Form 10-K"). In evaluating our risks, readers should carefully consider the risk factors discussed in our 2016 Annual Report on Form 10-K, which could materially affect our business, financial condition or operating results, in addition to the other information set forth in this report and in our other filings with the Securities and Exchange Commission.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

As indicated in the following table, we did not repurchase shares of our common stock or our Series B 6.75% convertible perpetual preferred stock during the three-month period ended December 31, 2016:

	Common Stock				Series B 6.75% Convertible Perpetual Preferred Stock
Period (1)	Total Number of Shares Repurchased	Average Price Paid Per Share (2)		Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs (3)	Total Number of Shares Repurchased	Average Price Paid Per Share (2)		Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs (3)	Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (3)
October 1-31, 2016	—	$	—	—	—	$	—	—	$	100,000,000
November 1-30, 2016	—	—		—	—	—		—	100,000,000
December 1-31, 2016	—	—		—	—	—		—	100,000,000
Total	—	$	—	—	—	$	—	—	$	100,000,000

⁽¹⁾  Repurchases are based on the date the shares were traded. This presentation differs from the consolidated statement of cash flows, where the cost of share repurchases is based on the date the transactions were settled.

⁽²⁾  Amounts listed for average price paid per share include broker commissions paid in the transactions.

⁽³⁾  A stock repurchase plan, which was authorized by our Board of Directors, became effective and was publicly announced on November 5, 2015. This stock repurchase plan authorized the purchase of up to $100 million in common and/or preferred stock in open market or privately negotiated transactions, subject to market conditions and other factors. This stock repurchase program will expire on November 15, 2017, or when we have exhausted the funds authorized for the program. The conversion of the shares of our Series B 6.75% Convertible Perpetual Preferred Stock did not affect our stock repurchase plan.

32

ITEM 6.   EXHIBITS

12	Ratio of Earnings to Fixed Charges, and Ratio of Earnings to Combined Fixed Charges and Preference Dividends.*
31.1	Certification of Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.*
32.1	Certification of Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) Pursuant to 18 U.S.C. Section 1350.*
101	Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended December 31, 2016, formatted in XBRL (eXtensible Business Reporting Language)).*
	Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Consolidated Statements of Income and Comprehensive Income for the three and nine months ended December 31, 2016 and 2015, (ii) the Consolidated Balance Sheets at December 31, 2016, December 31, 2015, and March 31, 2016, (iii) the Consolidated Statements of Cash Flows for the nine months ended December 31, 2016 and 2015, and (iv) the Notes to Consolidated Financial Statements.

__________

*Filed herewith

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	February 7, 2017	UNIVERSAL CORPORATION
		(Registrant)
		/s/ George C. Freeman, III
		George C. Freeman, III, Chairman, President, and Chief Executive Officer
		(Principal Executive Officer and Principal Financial Officer)
		/s/ Robert M. Peebles
		Robert M. Peebles, Vice President and Controller
		(Principal Accounting Officer)

34

Exhibit Index

Exhibit No.	Description
12	Ratio of Earnings to Fixed Charges, and Ratio of Earnings to Combined Fixed Charges and Preference Dividends.*
31.1	Certification of Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.*
32.1	Certification of Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) Pursuant to 18 U.S.C. Section 1350.*
101	Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended December 31, 2016, formatted in XBRL (eXtensible Business Reporting Language)).*
	Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Consolidated Statements of Income and Comprehensive Income for the three and nine months ended December 31, 2016 and 2015, (ii) the Consolidated Balance Sheets at December 31, 2016, December 31, 2015, and March 31, 2016, (iii) the Consolidated Statements of Cash Flows for the nine months ended December 31, 2016 and 2015, and (iv) the Notes to Consolidated Financial Statements.

__________

*Filed herewith

35

EX-12.0

Exhibit 12

UNIVERSAL CORPORATION

RATIO OF EARNINGS TO FIXED CHARGES

AND

RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERENCE DIVIDENDS

	Three Months Ended December 31,				Nine Months Ended December 31,
(in thousands, except for ratios)	2016		2015		2016		2015
Earnings
Pretax income before equity in pretax earnings of unconsolidated affiliates	$	79,638	$	65,730	$	107,209	$	90,366
Fixed charges (net of interest capitalized)	4,486		4,695		13,677		13,846
Distribution of earnings from unconsolidated affiliates	5,078		3,422		5,078		3,422
Total Earnings	$	89,202	$	73,847	$	125,964	$	107,634
Fixed Charges and Preference Dividends
Interest expense	$	4,051	$	3,937	$	12,440	$	11,733
Interest capitalized	—		—		—		—
Amortization of premiums, discounts, and debt issuance costs (1)	—		213		—		638
Interest component of rent expense	435		545		1,237		1,475
Total Fixed Charges	4,486		4,695		13,677		13,846
Dividends on convertible perpetual preferred stock (pretax)	5,673		5,673		17,018		17,018
Total Fixed Charges and Preference Dividends	$	10,159	$	10,368	$	30,695	$	30,864
Ratio of Earnings to Fixed Charges	19.88		15.73		9.21		7.77
Ratio of Earnings to Combined Fixed Charges and Preference Dividends	8.78		7.12		4.10		3.49

⁽¹⁾ The Company began reporting the amortization of premiums, discounts, and debt issuance costs in interest expense effective April 1, 2016 (the beginning of fiscal year 2017). No reclassification has been made for prior reporting periods since the amounts are not material.

EX-31.1

Exhibit 31.1

CERTIFICATION

I, George C. Freeman, III, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Universal Corporation for the period ended December 31, 2016;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 7, 2017	/s/ George C. Freeman, III
	George C. Freeman, III
	Chairman, President, and Chief Executive Officer
	(Principal Executive Officer and Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Universal Corporation (the “Company”) on Form 10-Q for the period ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, George C. Freeman, III, certify, to the best of my knowledge and belief, that

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 7, 2017	/s/ George C. Freeman, III
	George C. Freeman, III
	Chairman, President, and Chief Executive Officer
	(Principal Executive Officer and Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document And Entity Information - shares	9 Months Ended
	Dec. 31, 2016	Feb. 03, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Entity Registrant Name	UNIVERSAL CORP /VA/
Entity Central Index Key	0000102037
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		25,273,449

XML

Consolidated Statements Of Income And Comprehensive Income - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Sales and other operating revenues		$ 668,771	$ 584,592	$ 1,421,188	$ 1,316,393
Costs and Expenses
Cost of goods sold		533,318	464,686	1,145,694	1,050,004
Selling, general and administrative expenses		52,068	54,081	153,101	166,187
Other Income	[1]	0	3,390	0	3,390
Restructuring and impairment costs	[2]	178	0	3,860	2,389
Operating income		83,207	69,215	118,533	101,203
Equity in pretax earnings of unconsolidated affiliates	[3]	4,495	2,326	5,625	2,556
Interest income		482	452	1,116	896
Interest expense		4,051	3,937	12,440	11,733
Income before income taxes		84,133	68,056	112,834	92,922
Income tax expense		27,071	21,441	36,778	27,368
Net income		57,062	46,615	76,056	65,554
Less: net income)attributable to noncontrolling interests in subsidiaries		(3,415)	(2,081)	(2,621)	(4,502)
Net income attributable to Universal Corporation		53,647	44,534	73,435	61,052
Dividends on Universal Corporation convertible perpetual preferred stock		(3,687)	(3,687)	(11,061)	(11,061)
Earnings available to Universal Corporation common shareholders		$ 49,960	$ 40,847	$ 62,374	$ 49,991
Earnings per share attributable to Universal Corporation common shareholders:
Basic		$ 2.17	$ 1.80	$ 2.73	$ 2.20
Diluted		$ 1.92	$ 1.60	$ 2.63	$ 2.18
Weighted average common shares outstanding:
Basic		22,982,473	22,717,043	22,831,717	22,671,943
Diluted		27,996,583	27,854,908	27,967,215	22,957,050
Total comprehensive income:
Total comprehensive income, net of income taxes		$ 58,717	$ 47,794	$ 76,038	$ 69,644
Less: comprehensive income attributable to noncontrolling interests, net of income taxes		(3,214)	(2,042)	(1,976)	(4,037)
Comprehensive income attributable to Universal Corporation, net of income taxes		$ 55,503	$ 45,752	$ 74,062	$ 65,607
Dividends declared per common share		$ 0.54	$ 0.53	$ 1.60	$ 1.57

[1] Other income represents a gain from remeasuring to fair value the Company's original 50% ownership interest in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner. This item is excluded from segment operating income, but is included in consolidated operating income in the consolidated statements of income and comprehensive income.

[2] Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

[3] Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
ASSETS
Cash and cash equivalents	$ 411,507	$ 319,447	$ 167,625
Accounts receivable, net	280,978	428,659	267,632
Advances to suppliers, net	93,175	101,890	84,905
Accounts receivable - unconsolidated affiliates	2,073	2,316	762
Inventories - at lower of cost or market:
Tobacco	736,368	637,132	965,917
Other	67,638	60,888	65,123
Prepaid income taxes	11,419	17,814	16,359
Other current assets	61,856	70,400	67,456
Total current assets	1,665,014	1,638,546	1,635,779
Property, plant and equipment
Land	22,760	22,987	22,870
Buildings	264,485	264,838	256,970
Machinery and equipment	603,860	591,327	591,292
Total property, plant and equipment	891,105	879,152	871,132
Less: accumulated depreciation	(569,697)	(553,265)	(545,518)
Property, plant and equipment, net	321,408	325,887	325,614
Other assets
Goodwill and other intangibles	98,869	99,071	99,035
Investments in unconsolidated affiliates	75,574	82,441	75,351
Deferred income taxes	24,266	23,853	38,750
Other noncurrent assets	41,798	61,379	52,245
Total other assets	240,507	266,744	265,381
Total assets	2,226,929	2,231,177	2,226,774
LIABILITIES AND SHAREHOLDERS' EQUITY
Notes payable and overdrafts	52,052	66,179	65,894
Accounts payable and accrued expenses	131,925	120,527	132,572
Accounts payable - unconsolidated affiliates	10,522	8,343	21,768
Customer advances and deposits	14,201	16,438	41,209
Accrued compensation	22,800	27,593	20,681
Income taxes payable	7,239	7,190	5,893
Current portion of long-term debt	0	0	0
Total current liabilities	238,739	246,270	288,017
Long-term debt	368,645	368,380	368,292
Pensions and other postretirement benefits	78,930	92,177	90,643
Other long-term liabilities	30,038	41,794	33,179
Deferred income taxes	29,075	29,494	27,447
Total liabilities	745,427	778,115	807,578
Shareholders' equity
Common stock, no par value, 100,000,000 shares authorized, 25,270,976 shares issued and outstanding (22,717,448 at December 31, 2015, and 22,717,735 at March 31, 2016)	319,509	208,946	206,941
Retained earnings	1,090,148	1,066,064	1,033,986
Accumulated other comprehensive loss	(71,723)	(72,350)	(70,439)
Total Universal Corporation shareholders' equity	1,441,946	1,414,222	1,382,050
Noncontrolling interests in subsidiaries	39,556	38,840	37,146
Total shareholders' equity	1,481,502	1,453,062	1,419,196
Total liabilities and shareholders' equity	2,226,929	2,231,177	2,226,774
Series A Junior Participating Preferred Stock [Member]
Shareholders' equity
Preferred Stock	0	0	0
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Shareholders' equity
Preferred Stock	$ 104,012	$ 211,562	$ 211,562

XML

Consolidated Balance Sheets (Parenthetical) - shares	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Common Stock [Member]
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	25,270,976	22,717,735	22,717,448
Common stock, shares outstanding	25,270,976	22,717,735	22,717,448
Series A Junior Participating Preferred Stock [Member]
Preferred stock, shares authorized	500,000	500,000	500,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Preferred stock, shares authorized	220,000	220,000	220,000
Preferred stock, shares issued	107,418	218,490	218,490
Preferred stock, shares outstanding	107,418	218,490	218,490

XML

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands		9 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		$ 76,056	$ 65,554
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		26,107	27,221
Net provision for losses (recoveries) on advances and guaranteed loans to suppliers		414	(1,026)
Foreign currency remeasurement loss (gain), net		12,493	21,492
Fair value gain upon acquisition of partner's interest in joint venture		0	(3,390)
Restructuring and impairment costs	[1]	3,860	2,389
Other, net		7,290	18,004
Changes in operating assets and liabilities, net		56,533	(120,045)
Net cash provided by operating activities		182,753	10,199
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment		(28,544)	(38,504)
Purchase of partner's interest in joint venture, net of cash held by the business		0	(5,964)
Proceeds from sale of property, plant and equipment		665	1,380
Other Investing Activities		0	(398)
Net cash used by investing activities		(27,879)	(43,486)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance (repayment) of short-term debt, net		(11,299)	4,168
Dividends paid to noncontrolling interests		(1,260)	(1,260)
Dividends paid on convertible perpetual preferred stock		(11,061)	(11,061)
Dividends paid on common stock		(36,181)	(35,349)
Other		(2,256)	(3,736)
Net cash used by financing activities		(62,057)	(47,238)
Effect of exchange rate changes on cash		(757)	(633)
Net increase (decrease) in cash and cash equivalents		92,060	(81,158)
Cash and cash equivalents at beginning of year		319,447	248,783
Cash and cash equivalents at end of period		411,507	$ 167,625
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Non-cash reclassification of preferred stock converted		$ 107,600
Preferred stock, shares converted to common stock		111,072

[1] Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

XML

Basis Of Presentation

9 Months Ended

Dec. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis Of Presentation

BASIS OF PRESENTATION

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the leading global leaf tobacco supplier. Because of the seasonal nature of the Company’s business, the results of operations for any fiscal quarter will not necessarily be indicative of results to be expected for other quarters or a full fiscal year. All adjustments necessary to state fairly the results for the period have been included and were of a normal recurring nature. Certain amounts in prior year statements have been reclassified to conform to the current year presentation. This Form 10-Q should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2016.

XML

Accounting Pronouncements

9 Months Ended

Dec. 31, 2016

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Accounting Pronouncements

ACCOUNTING PRONOUNCEMENTS

Pronouncements Adopted in Fiscal Year 2017

In April 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for fiscal years beginning after December 31, 2015. The Company adopted ASU 2015-03 effective as of April 1, 2016, the beginning of fiscal year 2017. The implementation of ASU 2015-03, which requires retrospective application, resulted in a $1.8 million and $1.6 million reclassification of unamortized debt issuance costs from other noncurrent assets to long-term debt for the comparative prior periods ended December 31, 2015 and March 31, 2016, respectively.

In May 2015, the FASB issued Accounting Standards Update No. 2015-07, "Fair Value Measurement, Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share or its Equivalent" ("ASU 2015-07"). ASU 2015-07 removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient and eliminates certain disclosures for investments that are eligible to be measured at fair value using the net asset value per share practical expedient. The Company adopted ASU 2015-07 effective as of April 1, 2016, the beginning of fiscal year 2017. Disclosures for all periods presented in Note 8 - Fair Value Measurements were adjusted accordingly.

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, "Compensation - Stock Compensation" ("ASU 2016-09"). ASU 2016-09 provides simplification for the accounting for employee stock-based payment transactions, including the related income tax consequences, treatment of excess tax benefits in determining income tax expense, the classification of awards as either equity or liabilities, and the classification of transactions in the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2017, with early adoption permitted. The Company early adopted ASU 2016-09 effective as of April 1, 2016. Effective with the adoption of ASU 2016-09, employees that the Company has a statutory requirement to withhold taxes on behalf of can now elect to withhold income taxes upon settlement of stock-based compensation awards up to the maximum statutory tax rate without requiring classification of the awards as a liability. As required by ASU 2016-09, employee tax withholding payments and excess tax benefits resulting from stock-based compensation have been classified as financing activities and operating activities, respectively, in the consolidated statements of cash flows for all periods presented.

Pronouncements to be Adopted in Future Periods

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting principles (“U.S. GAAP”).  ASU 2014-09 was developed under a joint project with the International Accounting Standards Board (“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting Standards.  Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.  The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.  It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management judgment and involve more estimates than the current guidance.  ASU 2014-09 is effective for annual periods beginning after December 15, 2017, including all interim periods within the year of adoption.   Companies are allowed to select between two transition methods:  (1) a full retrospective transition method with the application of the new guidance to each prior reporting period presented, or (2) a retrospective transition method that recognizes the cumulative effect on prior periods at the date of adoption together with additional footnote disclosures. Since the issuance of ASU 2014-09, the FASB has issued several amendments to provide additional supplemental guidance on certain aspects of the original pronouncement.  Universal expects to adopt ASU 2014-09 and the related supplemental amendments effective April 1, 2018, which is the beginning of the fiscal year ending March 31, 2019.  The Company is currently evaluating the impact that the adoption of ASU 2014-09 and the related amendments will have on its consolidated financial statements and has not made a decision on the method of adoption.

In July 2015, the FASB issued Accounting Standards Update No. 2015-11, “Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 requires that most inventory be measured at the lower of cost or net realizable value. ASU 2015-11 defines net realizable value as the "estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal, and transportation." ASU 2015-11 is effective for fiscal years beginning after December 31, 2016. The Company is currently evaluating the impact that the adoption of ASU 2015-11 will have on its consolidated financial statements. ASU 2015-11 will be applied prospectively after the date of adoption, as required by the guidance.

In January 2016, the FASB issued Accounting Standards Update No. 2016-01, “Financial Instruments-Recognition and Measurement of Financial Assets and Financial Liabilities” ("ASU 2016-01"). ASU 2016-01 requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in consolidation of the investee). This guidance is effective for fiscal years beginning after December 15, 2017. The Company is currently evaluating the impact that the adoption of ASU 2016-01 will have on its consolidated financial statements.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires a lessee to recognize lease payment obligations as a lease liability and the corresponding right-of-use asset as a leased asset in the balance sheet for the term of the lease. This guidance supersedes Topic 840 “Leases” and is effective for fiscal years beginning after December 15, 2018. The Company will be required to adopt ASU 2016-02 effective April 1, 2019, which is the beginning of its fiscal year ending March 31, 2020, and is currently evaluating the impact that the updated guidance will have on its consolidated financial statements.

In August 2016, the FASB issued Accounting Standards Update No. 2016-15, "Statement of Cash Flows" ("ASU 2016-15"). ASU 2016-15 is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. This guidance is effective for fiscal years beginning after December 15, 2017, with early adoption permitted. The Company is currently evaluating the impact that the adoption of ASU 2016-15 will have on its consolidated financial statements.

XML

Guarantees, Other Contingent Liabilities, And Other Matters

9 Months Ended

Dec. 31, 2016

Guarantees, Other Contingent Liabilities, And Other Matters [Abstract]

Guarantees, Other Contingent Liabilities, And Other Matters

GUARANTEES, OTHER CONTINGENT LIABILITIES, AND OTHER MATTERS

Guarantees and Other Contingent Liabilities

Guarantees of Bank Loans and Other Contingent Liabilities

Guarantees of bank loans to tobacco growers for crop financing have long been industry practice in Brazil and support the farmers’ production of tobacco there. The Company's operating subsidiary in Brazil had guarantees outstanding at December 31, 2016, all of which expire within one year. The subsidiary withholds payments due to the farmers on delivery of tobacco and forwards those payments to the third-party banks. Failure of farmers to deliver sufficient quantities of tobacco to the subsidiary to cover its obligations to the third-party banks could result in a liability for the subsidiary under the related guarantees; however, in that case, the subsidiary would have recourse against the farmers. The maximum potential amount of future payments that the Company’s subsidiary could be required to make at December 31, 2016, was the face amount, $35 million including unpaid accrued interest ($27 million at December 31, 2015, and $13 million at March 31, 2016). The fair value of the guarantees was a liability of approximately $2 million at December 31, 2016 ($1 million at December 31, 2015, and $2 million at March 31, 2016). In addition to these guarantees, the Company has other contingent liabilities, primarily related to outstanding letters of credit, totaling approximately $2 million at December 31, 2016.

Value-Added Tax Assessments in Brazil

As further discussed below, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) in connection with their normal operations. In Brazil, VAT is assessed at the state level when green tobacco is transferred between states. The Company’s operating subsidiary there pays VAT when tobaccos grown in the states of Santa Catarina and Parana are transferred to its factory in the state of Rio Grande do Sul for processing. The subsidiary has received assessments for additional VAT plus interest and penalties from tax authorities for the states of Santa Catarina and Parana based on audits of the subsidiary’s VAT filings for specified periods. In June 2011, tax authorities for the state of Santa Catarina issued assessments for tax, interest, and penalties for periods from 2006 through 2009 totaling approximately $15 million. In September 2014, tax authorities for the state of Parana issued an assessment for tax, interest, and penalties for periods from 2009 through 2014 totaling approximately $17 million. Those amounts are based on the exchange rate for the Brazilian currency at December 31, 2016. Management of the operating subsidiary and outside counsel believe that errors were made by the tax authorities for both states in determining all or significant portions of these assessments and that various defenses support the subsidiary’s positions.

With respect to the Santa Catarina assessments, the subsidiary took appropriate steps to contest the full amount of the claims. As of December 31, 2016, a portion of the subsidiary’s arguments had been accepted, and the outstanding assessment had been reduced. The reduced assessment, together with the related accumulated interest through the end of the current reporting period, totaled approximately $14 million (at the December 31, 2016 exchange rate). The subsidiary is continuing to contest the full remaining amount of the assessment. While the range of reasonably possible loss is zero up to the full $14 million remaining assessment, based on the strength of the subsidiary’s defenses, no loss within that range is considered probable at this time and no liability has been recorded at December 31, 2016.

With respect to the Parana assessment, management of the subsidiary and outside counsel challenged the full amount of the claim. A significant portion of the Parana assessment was based on positions taken by the tax authorities that management and outside counsel believe deviate significantly from the underlying statutes and relevant case law. In addition, under the law, the subsidiary’s tax filings for certain periods covered in the assessment were no longer open to any challenge by the tax authorities. In December 2015, the Parana tax authorities withdrew the initial claim, and subsequently issued a new assessment covering the same tax periods. The new assessment totaled approximately $5 million at the December 31, 2016 exchange rate, reflecting a substantial reduction from the original $17 million assessment. Notwithstanding the reduction, management and outside counsel continue to believe that the new assessment is not supported by the underlying statutes and relevant case law and have challenged the full amount of the claim. The range of reasonably possible loss is considered to be zero up to the full $5 million assessment. However, based on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been recorded at December 31, 2016.

In both states, the process for reaching a final resolution to the assessments is expected to be lengthy, and management is not currently able to predict when either case will be concluded. Should the subsidiary ultimately be required to pay any tax, interest, or penalties in either case, the portion paid for tax would generate value-added tax credits that the subsidiary may be able to recover.

Other Legal and Tax Matters

Various subsidiaries of the Company are involved in litigation and tax examinations incidental to their business activities.  While the outcome of these matters cannot be predicted with certainty, management is vigorously defending the matters and does not currently expect that any of them will have a material adverse effect on the Company’s business or financial position.  However, should one or more of these matters be resolved in a manner adverse to management’s current expectation, the effect on the Company’s results of operations for a particular fiscal reporting period could be material.

Advances to Suppliers

In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed, fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement of those inputs. These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances to suppliers in the consolidated balance sheets. In several origins, the Company has made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure. In some years, due to low crop yields and other factors, individual farmers may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of those advances into future crop years. The long-term portion of advances is included in other noncurrent assets in the consolidated balance sheets. Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers totaled $125 million at December 31, 2016, $116 million at December 31, 2015, and $134 million at March 31, 2016. The related valuation allowances totaled $30 million at December 31, 2016, $28 million at December 31, 2015, and $29 million at March 31, 2016, and were estimated based on the Company’s historical loss information and crop projections. The allowances were increased by net provisions of approximately $0.4 million and reduced by net recoveries of $1 million in the nine-month periods ended December 31, 2016 and 2015, respectively. These net provisions and recoveries are included in selling, general, and administrative expenses in the consolidated statements of income. Interest on advances is recognized in earnings upon the farmers’ delivery of tobacco in payment of principal and interest.

Recoverable Value-Added Tax Credits

In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services. In some countries, VAT is a national tax, and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at which the tax is assessed. When tobacco is sold to customers in the country of origin, the operating subsidiaries generally collect VAT on those sales. The subsidiaries are normally permitted to offset their VAT payments against the collections and remit only the incremental VAT collections to the tax authorities. When tobacco is sold for export, VAT is normally not assessed. In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream sales are often not sufficient to fully offset the subsidiaries’ VAT payments. In those situations, unused VAT credits can accumulate. Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time and it is not uncommon for refund applications to be challenged or rejected in part on technical grounds. Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits. Due to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time. The Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred. At December 31, 2016, the aggregate balance of recoverable tax credits held by the Company’s subsidiaries totaled approximately $41 million ($51 million at December 31, 2015, and $52 million at March 31, 2016), and the related valuation allowances totaled approximately $11 million ($19 million at December 31, 2015, and $19 million at March 31, 2016). The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.

Conversion of Series B 6.75% Convertible Perpetual Preferred Stock

In December 2016, holders of 111,072 shares of the Company’s Series B 6.75% Convertible Perpetual Preferred Stock (approximately 50.8% of the outstanding shares) voluntarily exercised their conversion rights under the original issuance terms of the preferred shares. The Company chose to satisfy the full conversion obligation for those preferred shares with shares of its common stock, issuing 2,487,118 common shares at the applicable conversion rate in exchange for the preferred shares tendered. The consolidated balance sheet at December 31, 2016 reflects a non-cash reclassification of $107.6 million from preferred stock to common stock to reflect the conversion of those preferred shares.

On January 9, 2017, the Company announced a mandatory conversion of all 107,418 remaining outstanding shares of the preferred stock after meeting the requirements to initiate the mandatory conversion under the original terms of the preferred shares. The Company chose to satisfy the full conversion obligation for the mandatory conversion in cash, paying approximately $178.4 million for those preferred shares on January 31, 2017 to complete the conversion.

With the completion of the mandatory conversion in January 2017, the Company’s outstanding equity securities consist only of its common stock. Dividend payments on the preferred shares, which previously totaled approximately $15 million annually, have been discontinued. Although the conversions of the preferred stock into common stock or for cash do not impact the Company’s net income, the shares converted for cash under the mandatory conversion in January 2017 will result in a one-time reduction of retained earnings of approximately $74.4 million during the quarter ending March 31, 2017, representing the excess of the conversion cost over the carrying value of those shares. The reduction in retained earnings will also result in a corresponding one-time reduction of earnings available to common shareholders for the quarter and fiscal year ending March 31, 2017 for purposes of determining the amounts reported for basic and diluted earnings per share for those periods.

XML

Restructuring Costs Restructuring Costs

9 Months Ended

Dec. 31, 2016

Restructuring Costs [Abstract]

Restructuring Costs

RESTRUCTURING AND IMPAIRMENT COSTS

Universal continually reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes. Restructuring and impairment costs are periodically incurred in connection with those activities.     For the reporting periods ended December 31, 2016 and 2015, the majority of restructuring costs incurred related to operations that are part of the Other Regions reportable segment of the Company's Flue-Cured and Burley Tobacco Operations.

Quarter andNine Months Ended December 31, 2016

For the quarter and nine months ended December 31, 2016, the Company recorded restructuring and impairment costs totaling $0.2 million and $3.9 million, respectively, primarily related to the Company's decision to close its tobacco processing facility in Hungary. The Company is now processing tobaccos sourced from Hungary in the Company's facilities in Italy. The restructuring and impairment costs incurred for the change in operations in Hungary included statutory employee termination benefits and impairment charges related to certain property and equipment. Substantially all of the termination benefits were paid before December 31, 2016.

Nine Months Ended December 31, 2015

In the first quarter of fiscal year 2016, the Company recorded restructuring and impairment costs totaling $2.4 million related to the scale back of its operations in Zambia. Those costs included statutory employee termination benefits, impairment charges related to outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment charges on certain property and equipment. The majority of the termination benefits were paid during fiscal year 2016.

XML

Earnings Per Share

9 Months Ended

Dec. 31, 2016

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:

	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands, except share and per share data)	2016			2015			2016			2015
Basic Earnings Per Share
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$	53,647		$	44,534		$	73,435		$	61,052
Less: Dividends on convertible perpetual preferred stock	(3,687		)	(3,687		)	(11,061		)	(11,061		)
Earnings available to Universal Corporation common shareholders for calculation of basic earnings per share	49,960			40,847			62,374			49,991
Denominator for basic earnings per share
Weighted average shares outstanding	22,982,473			22,717,043			22,831,717			22,671,943
Basic earnings per share	$	2.17		$	1.80		$	2.73		$	2.20
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$	49,960		$	40,847		$	62,374		$	49,991
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	3,687			3,687			11,061			—
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	53,647			44,534			73,435			49,991
Denominator for diluted earnings per share
Weighted average shares outstanding	22,982,473			22,717,043			22,831,717			22,671,943
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock	4,693,155			4,857,262			4,816,904			—
Employee share-based awards	320,955			280,603			318,594			285,107
Denominator for diluted earnings per share	27,996,583			27,854,908			27,967,215			22,957,050
Diluted earnings per share	$	1.92		$	1.60		$	2.63		$	2.18

In December 2016, 111,072 shares of the Company’s Series B 6.75% Convertible Perpetual Preferred Stock were converted into approximately 2.5 million of the Company's common stock. The effect from the conversion on the computation of basic and diluted earnings per share for the three and nine months ended December 31, 2016, is included in the table above. See Note 3 for additional information.

The Company had the following potentially dilutive securities (stock appreciation rights) outstanding for the nine months ended December 31, 2016 and 2015 that were not included in the computation of diluted earnings per share because their exercise price exceeded the market price of the Company's common stock, and thus their effect would have been antidilutive:

	Nine Months Ended December 31,
	2016		2015
Potentially dilutive securities	122,200		133,600
Weighted-average exercise price	$	62.66	$	62.66

XML

Income Taxes

9 Months Ended

Dec. 31, 2016

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

The Company is subject to the tax laws of many jurisdictions. Changes in tax laws or the interpretation of tax laws can affect the Company’s earnings, as can the resolution of pending and contested tax issues. The Company's consolidated effective income tax rate on pretax earnings is affected by a number of factors, including the mix of domestic and foreign earnings, the effect of exchange rate changes on deferred taxes, and the Company’s ability to utilize foreign tax credits.

The Company's consolidated effective income tax rates were approximately 32% and 33% for the quarter and nine months ended December 31, 2016, respectively, compared to approximately 32% and 29% for the quarter and nine months ended December 31, 2015, respectively. The effective rate for the prior year nine-month period was lower primarily due to the effects of changes in currency exchange rates on deferred income tax assets and liabilities of foreign subsidiaries. The effective tax rate for the current year period more closely approximates the 35% U.S. federal statutory rate because the effects of currency exchange rate changes have not been significant.

XML

Derivatives And Hedging Activities

9 Months Ended

Dec. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives And Hedging Activities

DERIVATIVES AND HEDGING ACTIVITIES

Universal is exposed to various risks in its worldwide operations and uses derivative financial instruments to manage two specific types of risks – interest rate risk and foreign currency exchange rate risk. Interest rate risk has been managed by entering into interest rate swap agreements, and foreign currency exchange rate risk has been managed by entering into forward foreign currency exchange contracts. However, the Company’s policy also permits other types of derivative instruments. In addition, foreign currency exchange rate risk is also managed through strategies that do not involve derivative instruments, such as using local borrowings and other approaches to minimize net monetary positions in non-functional currencies. The disclosures below provide additional information about the Company’s hedging strategies, the derivative instruments used, and the effects of these activities on the consolidated statements of income and comprehensive income and the consolidated balance sheets. In the consolidated statements of cash flows, the cash flows associated with all of these activities are reported in net cash provided by operating activities.

Hedging Strategy for Interest Rate Risk

In January 2015, the Company entered into receive-floating/pay-fixed interest rate swap agreements that were designated and qualified as hedges of the exposure to changes in interest payment cash flows created by fluctuations in variable interest rates on two outstanding non-amortizing bank term loans. Although no significant ineffectiveness is expected with this hedging strategy, the effectiveness of the interest rate swaps is evaluated on a quarterly basis. At December 31, 2016, the total notional amount of the interest rate swaps was $370 million, which corresponded with the aggregate outstanding balance of the term loans.

Cash Flow Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Forecast Purchases of Tobacco and Related Processing Costs

The majority of the tobacco production in most countries outside the United States where Universal operates is sold in export markets at prices denominated in U.S. dollars. However, purchases of tobacco from farmers and most processing costs (such as labor and energy) in those countries are usually denominated in the local currency. Changes in exchange rates between the U.S. dollar and the local currencies where tobacco is grown and processed affect the ultimate U.S. dollar cost of the processed tobacco. From time to time, the Company enters into forward contracts to sell U.S. dollars and buy the local currency at future dates that coincide with the expected timing of a portion of the tobacco purchases and processing costs. This strategy offsets the variability of future U.S. dollar cash flows for tobacco purchases and processing costs for the foreign currency notional amount hedged. This hedging strategy has been used mainly for tobacco purchases and processing costs in Brazil. The aggregate U.S. dollar notional amount of forward contracts entered for these purposes during the first nine months of fiscal years 2017 and 2016 was as follows:

	Nine Months Ended December 31,
(in millions of dollars)	2016		2015
Tobacco purchases	$	9.7	$	19.8
Processing costs	2.7		5.6
Total	$	12.4	$	25.4

The reduced U.S. dollar notional amounts for tobacco purchases and processing costs hedged during the nine months ended December 31, 2016 reflect the reduced size of the 2016 Brazilian crop and a variation in the timing of fixed-price orders from customers for their purchases from the respective crop years. All contracts related to tobacco purchases were designated and qualify as hedges of the future cash flows associated with the forecast purchases of tobacco. As a result, except for amounts related to any ineffective portion of the hedging strategy or any early de-designation of the hedge arrangement, changes in fair values of the forward contracts have been recognized in comprehensive income as they occurred, but only recognized in earnings upon sale of the related tobacco to third-party customers. Forward contracts related to processing costs have not been designated as hedges, and gains and losses on those contracts have been recognized in earnings on a mark-to-market basis.

All forward contracts to hedge purchases of the 2016 crop in Brazil matured and settled by December 31, 2016. For substantially all hedge gains and losses recorded in accumulated other comprehensive loss at December 31, 2016, the Company expects to complete the sale of the tobacco and recognize the amounts in earnings during fiscal year 2017.

Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Net Local Currency Monetary Assets and Liabilities of Foreign Subsidiaries

Most of the Company’s foreign subsidiaries transact the majority of their sales in U.S. dollars and finance the majority of their operating requirements with U.S. dollar borrowings, and therefore use the U.S. dollar as their functional currency. These subsidiaries normally have certain monetary assets and liabilities on their balance sheets that are denominated in the local currency. Those assets and liabilities can include cash and cash equivalents, accounts receivable and accounts payable, advances to farmers and suppliers, deferred income tax assets and liabilities, recoverable value-added taxes, and other items. Net monetary assets and liabilities denominated in the local currency are remeasured into U.S. dollars each reporting period, generating gains and losses that the Company records in earnings as a component of selling, general, and administrative expenses. The level of net monetary assets or liabilities denominated in the local currency normally fluctuates throughout the year based on the operating cycle, but it is most common for monetary assets to exceed monetary liabilities, sometimes by a significant amount. When this situation exists and the local currency weakens against the U.S. dollar, remeasurement losses are generated. Conversely, remeasurement gains are generated on a net monetary asset position when the local currency strengthens against the U.S. dollar. To manage a portion of its exposure to currency remeasurement gains and losses, the Company enters into forward contracts to buy or sell the local currency at future dates coinciding with expected changes in the overall net local currency monetary asset position of the subsidiary. Gains and losses on the forward contracts are recorded in earnings as a component of selling, general, and administrative expenses for each reporting period as they occur, and thus directly offset the related remeasurement losses or gains in the consolidated statements of income for the notional amount hedged. The Company does not designate these contracts as hedges for accounting purposes. The contracts are generally arranged to hedge the subsidiary's projected exposure to currency remeasurement risk for specified periods of time, and new contracts are entered as necessary throughout the year to replace previous contracts as they mature. The Company is currently using forward currency contracts to manage its exposure to currency remeasurement risk in Brazil.  The total notional amounts of contracts outstanding at December 31, 2016 and 2015 were approximately $23.4 million and $56.8 million, respectively. At March 31, 2016, the net local monetary asset position in Brazil was not significant, and there were no foreign currency contracts outstanding at that time to manage currency remeasurement risk. To further mitigate currency remeasurement exposure, the Company’s foreign subsidiaries may utilize short-term local currency financing during certain periods. This strategy, while not involving the use of derivative instruments, is intended to minimize the subsidiary’s net monetary position by financing a portion of the local currency monetary assets with local currency monetary liabilities, thus hedging a portion of the overall position.

Several of the Company’s foreign subsidiaries transact the majority of their sales and finance the majority of their operating requirements in their local currency, and therefore use their respective local currencies as the functional currency for reporting purposes. From time to time, these subsidiaries sell tobacco to customers in transactions that are not denominated in the functional currency. In those situations, the subsidiaries routinely enter into forward exchange contracts to offset currency risk for the period of time that a fixed-price order and the related trade account receivable are outstanding with the customer. The contracts are not designated as hedges for accounting purposes.

Effect of Derivative Financial Instruments on the Consolidated Statements of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements of income for the three- and nine-month periods ended December 31, 2016 and 2015:

	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	10,876		$	3,529		$	8,484		$	(2,527	)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	(987	)	$	(1,328	)	$	(3,135	)	$	(4,004	)
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings	$	—		$	—		$	—		$	—
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Floating rate interest payments on term loan
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	—		$	—		$	453		$	1,283
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	102		$	362		$	770		$	720
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings	$	—		$	—		$	246		$	745
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges - Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings	$	(1,576	)	$	(2,366	)	$	(2,932	)	$	6,014
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses

For the interest rate swap agreements, the effective portion of the gain or loss on the derivative is recorded in accumulated other comprehensive loss and any ineffective portion is recorded in selling, general and administrative expenses. For the forward foreign currency exchange contracts designated as cash flow hedges of tobacco purchases in Brazil, a net hedge gain of approximately $0.2 million remained in accumulated other comprehensive loss at December 31, 2016. That balance reflects gains and losses on contracts related to the 2016 crop, less the amount reclassified to earnings related to tobacco sold through December 31, 2016. The majority of the balance in accumulated other comprehensive loss is expected to be recognized in earnings as a component of cost of goods sold in fiscal year 2017 as the 2016 Brazilian crop tobacco is sold to customers. Based on the hedging strategy, as the gain or loss is recognized in earnings, it is expected to be offset by a change in the direct cost for the tobacco or by a change in sales prices if the strategy has been mandated by the customer. Generally, margins on the sale of the tobacco will not be significantly affected.

Effect of Derivative Financial Instruments on the Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets at December 31, 2016 and 2015, and March 31, 2016:

	Derivatives in a Fair Value Asset Position							Derivatives in a Fair Value Liability Position
	Balance Sheet Location	Fair Value as of						Balance Sheet Location	Fair Value as of
(in thousands of dollars)		December 31, 2016		December 31, 2015		March 31, 2016			December 31, 2016		December 31, 2015		March 31, 2016
Derivatives Designated as Hedging Instruments
Interest rate swap agreements	Other non-current assets	$	853	$	—	$	—	Other long-term liabilities	$	—	$	1,573	$	10,766
Forward foreign currency exchange contracts	Other current assets	—		—		475		Accounts payable and accrued expenses	—		—		—
Total		$	853	$	—	$	475		$	—	$	1,573	$	10,766
Derivatives Not Designated as Hedging Instruments
Forward foreign currency exchange contracts	Other current assets	$	4	$	540	$	297	Accounts payable and accrued expenses	$	1,229	$	90	$	5
Total		$	4	$	540	$	297		$	1,229	$	90	$	5

Substantially all of the Company's forward foreign exchange contracts are subject to master netting arrangements whereby the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts on a gross basis in the consolidated balance sheets.

XML

Fair Value Measurements

9 Months Ended

Dec. 31, 2016

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Universal measures certain financial and nonfinancial assets and liabilities at fair value based on applicable accounting guidance. The financial assets and liabilities measured at fair value include money market funds, trading securities associated with deferred compensation plans, interest rate swap agreements, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers. The application of the fair value guidance to nonfinancial assets and liabilities primarily includes the determination of fair value for goodwill and long-lived assets when indicators of potential impairment are present.

Under the accounting guidance, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The framework for measuring fair value is based on a fair value hierarchy that distinguishes between observable inputs and unobservable inputs. Observable inputs are based on market data obtained from independent sources. Unobservable inputs require the Company to make its own assumptions about the value placed on an asset or liability by market participants because little or no market data exists. There are three levels within the fair value hierarchy:

Level	Description
1	quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the reporting date;
2	quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and
3	unobservable inputs for the asset or liability.

As permitted under the accounting guidance, the Company uses net asset value per share ("NAV") as a practical expedient to measure the fair value of its money market funds. As discussed in Note 2, under updated accounting guidance adopted effective April 1, 2016, the fair values for those funds are no longer categorized within the fair value hierarchy and are presented under the heading "NAV" in the tables that follow in this disclosure.

In measuring the fair value of liabilities, the Company considers the risk of non-performance in determining fair value. Universal has not elected to report at fair value any financial instruments or any other assets or liabilities that are not required to be reported at fair value under current accounting guidance.

At December 31, 2016 and 2015, and at March 31, 2016, the Company had certain financial assets and financial liabilities that were required to be measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified based on how their values were determined under the fair value hierarchy or the NAV practical expedient:

	December 31, 2016
			Fair Value Hierarchy
(in thousands of dollars)	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	241,991	$	—	$	—	$	—	$	241,991
Trading securities associated with deferred compensation plans	—		17,210		—		—		17,210
Interest rate swap agreements	—		—		853		—		853
Forward foreign currency exchange contracts	—		—		4		—		4
Total financial assets measured and reported at fair value	$	241,991	$	17,210	$	857	$	—	$	260,058
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,844	$	1,844
Forward foreign currency exchange contracts	—		—		1,229		—		1,229
Total financial liabilities measured and reported at fair value	$	—	$	—	$	1,229	$	1,844	$	3,073

	December 31, 2015
			Fair Value Hierarchy
(in thousands of dollars)	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	26,578	$	—	$	—	$	—	$	26,578
Trading securities associated with deferred compensation plans	—		18,907		—		—		18,907
Forward foreign currency exchange contracts	—		—		540		—		540
Total financial assets measured and reported at fair value	$	26,578	$	18,907	$	540	$	—	$	46,025
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,469	$	1,469
Interest rate swap agreements	—		—		1,573		—		1,573
Forward foreign currency exchange contracts	—		—		90		—		90
Total financial liabilities measured and reported at fair value	$	—	$	—	$	1,663	$	1,469	$	3,132

	March 31, 2016
			Fair Value Hierarchy
(in thousands of dollars)	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	116,618	$	—	$	—	$	—	$	116,618
Trading securities associated with deferred compensation plans	—		17,817		—		—		17,817
Forward foreign currency exchange contracts	—		—		772		—		772
Total financial assets measured and reported at fair value	$	116,618	$	17,817	$	772	$	—	$	135,207
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,628	$	1,628
Interest rate swap agreements	—		—		10,766		—		10,766
Forward foreign currency exchange contracts	—		—		5		—		5
Total financial liabilities measured and reported at fair value	$	—	$	—	$	10,771	$	1,628	$	12,399

Money market funds

The fair value of money market funds, which are reported in cash and cash equivalents in the consolidated balance sheets, is based on NAV, which is the amount at which the funds are redeemable and is used as a practical expedient for fair value. These funds are not classified in the fair value hierarchy, but are disclosed as part of the fair value table above.

Trading securities associated with deferred compensation plans

Trading securities represent mutual fund investments that are matched to employee deferred compensation obligations. These investments are bought and sold as employees defer compensation, receive distributions, or make changes in the funds underlying their accounts. Quoted market prices (Level 1) are used to determine the fair values of the mutual funds.

Interest rate swap agreements

The fair values of interest rate swap agreements are determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, interest rate swaps are classified within Level 2 of the fair value hierarchy.

Forward foreign currency exchange contracts

The fair values of forward foreign currency exchange contracts are also determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, forward foreign currency exchange contracts are classified within Level 2 of the fair value hierarchy.

Guarantees of bank loans to tobacco growers

The Company guarantees bank loans to tobacco growers in Brazil for crop financing. In the event that the farmers default on their payments to the banks, the Company would be required to perform under the guarantees. The Company regularly evaluates the likelihood of farmer defaults based on an expected loss analysis and records the fair value of its guarantees as an obligation in its consolidated financial statements. The fair value of the guarantees is determined using the expected loss data for all loans outstanding at each measurement date. The present value of the cash flows associated with the estimated losses is then calculated at a risk-adjusted interest rate that is aligned with the expected duration of the liability and includes an adjustment for nonperformance risk. This approach is sometimes referred to as the “contingent claims valuation method.” Although historical loss data is an observable input, significant judgment is required in applying this information to the portfolio of guaranteed loans outstanding at each measurement date and in selecting a risk-adjusted interest rate. Significant increases or decreases in the risk-adjusted interest rate may result in a significantly higher or lower fair value measurement. The guarantees of bank loans to tobacco growers are therefore classified within Level 3 of the fair value hierarchy.

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 3) for the nine months ended December 31, 2016 and 2015 is provided below.

	Nine Months Ended December 31,
(in thousands of dollars)	2016			2015
Balance at beginning of year	$	1,628		$	1,674
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from portfolio)	(1,848		)	(1,826		)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,856			1,851
Change in discount rate and estimated collection period	55			76
Currency remeasurement	153			(306		)
Balance at end of period	$	1,844		$	1,469

Long-term Debt

The fair value of the Company’s long-term debt, including the current portion, was approximately $370 million at each of the balance sheet dates December 31, 2016, December 31, 2015, and March 31, 2016. The Company estimates the fair value of its long-term debt using Level 2 inputs which are based upon quoted market prices for the same or similar issues or on the current interest rates available to the Company for debt of similar terms and maturities.

XML

Pension And Other Postretirement Benefit Plans

9 Months Ended

Dec. 31, 2016

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Pension and Other Postretirement Benefits Disclosure

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

The Company sponsors several defined benefit pension plans covering U.S. salaried employees and certain foreign and other employee groups. These plans provide retirement benefits based primarily on employee compensation and years of service. The Company also sponsors defined benefit plans that provide postretirement health and life insurance benefits for eligible U.S. employees attaining specific age and service levels.

The components of the Company’s net periodic benefit cost were as follows:

	Pension Benefits						Other Postretirement Benefits
	Three Months Ended December 31,						Three Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
Service cost	$	1,343		$	1,469		$	73		$	106
Interest cost	2,453			2,345			378			387
Expected return on plan assets	(3,584		)	(3,574		)	(11		)	(15		)
Net amortization and deferral	843			1,201			(100		)	(44		)
Net periodic benefit cost	$	1,055		$	1,441		$	340		$	434

	Pension Benefits						Other Postretirement Benefits
	Nine Months Ended December 31,						Nine Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
Service cost	$	4,063		$	4,431		$	220		$	320
Interest cost	7,389			7,038			1,136			1,186
Expected return on plan assets	(10,762		)	(10,727		)	(33		)	(45		)
Net amortization and deferral	2,519			3,599			(300		)	(132		)
Net periodic benefit cost	$	3,209		$	4,341		$	1,023		$	1,329

The net periodic benefit cost for the Company's pension and other postretirement benefit plans has declined from the prior fiscal year, primarily reflecting actuarial gains from higher market discount rates applicable to the most recent actuarial measurement of benefit liabilities.

During the nine months ended December 31, 2016, the Company made contributions of approximately $10.4 million to its pension plans. Additional contributions of approximately $0.6 million are expected during the remaining three months of fiscal year 2017.

XML

Stock-Based Compensation

9 Months Ended

Dec. 31, 2016

Share-based Compensation [Abstract]

Stock-Based Compensation

STOCK-BASED COMPENSATION

Universal’s shareholders have approved Executive Stock Plans (“Plans”) under which officers, directors, and employees of the Company may receive grants and awards of common stock, restricted stock, restricted stock units (“RSUs”), performance share awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options. The Company’s practice is to award grants of stock-based compensation to officers on an annual basis at the first regularly-scheduled meeting of the Executive Compensation, Nominating and Corporate Governance Committee of the Board of Directors (the “Compensation Committee”) in the fiscal year following the public release of the Company’s financial results for the prior year. The Compensation Committee administers the Company’s Plans consistently, following previously defined guidelines. Awards of restricted stock, RSUs, PSAs, and SARs are currently outstanding under the Plans. The SARs have an exercise price equal to the closing price of a share of the Company's common stock on the grant date. They are settled in shares of common stock, vest in equal one-third tranches one, two, and three years after the grant date, and expire on the earlier of three years after the grantee’s retirement date or ten years after the grant date. The Company has not made grants of SARs since fiscal year 2012. The RSUs vest five years from the grant date and are then paid out in shares of common stock. Under the terms of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the same date as the original RSU grant. The PSAs vest at the end of a three years performance period that begins with the year of the grant, are paid out in shares of common stock shortly after the vesting date, and do not carry rights to dividends or dividend equivalents prior to vesting. Shares ultimately paid out under PSA grants are dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range from zero to 150% of the stated award. The Company’s outside directors automatically receive restricted stock units or shares of restricted stock following each annual meeting of shareholders. RSUs awarded to outside directors vest three years after the grant date, and restricted shares vest upon the individual’s retirement from service as a director.

As discussed in Note 2, effective April 1, 2016, the Company early adopted recently-issued updates to the accounting guidance for stock-based compensation. Those updates primarily related to the income tax consequences of stock-based payment transactions, the treatment of excess tax benefits in determining income tax expense, the classification of awards as either equity or liabilities, and the classification of transactions in the statement of cash flows.

During the nine-month periods ended December 31, 2016 and 2015, Universal issued the following stock-based awards, representing the regular annual grants to officers and outside directors of the Company:

	Nine Months Ended December 31,
	2016		2015
RSUs:
Number granted	63,425		67,750
Grant date fair value	$	55.93	$	52.10
PSAs:
Number granted	54,675		57,750
Grant date fair value	$	49.17	$	45.06

As indicated in the table above, the Compensation Committee awarded only grants of RSUs and PSAs in both the current and prior fiscal years, and did not award any other types of stock-based compensation.

Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of: (1) the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award. For employees who are already eligible to retire at the date an award is granted, the total fair value of all non-forfeitable awards is recognized as expense at the date of grant. As a result, Universal typically incurs higher stock compensation expense in the first quarter of each fiscal year when grants are awarded to officers than in the other three quarters. For PSAs, the Company generally recognizes fair value expense ratably over the performance and vesting period based on management’s judgment of the ultimate award that is likely to be paid out based on the achievement of the predetermined performance measures. The Company accounts for forfeitures of stock-based awards as they occur. For the nine-month periods ended December 31, 2016 and 2015, the Company recorded total stock-based compensation expense of approximately $4.8 million and $4.2 million, respectively. The Company expects to recognize stock-based compensation expense of approximately $1.1 million during the remaining three months of fiscal year 2017.

XML

Operating Segments

9 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Operating Segments

OPERATING SEGMENTS

The principal approach used by management to evaluate the Company’s performance is by geographic region, although the dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations. The Company evaluates the performance of its segments based on operating income after allocated overhead expenses (excluding significant non-recurring charges or credits), plus equity in the pretax earnings of unconsolidated affiliates.

Operating results for the Company’s reportable segments for each period presented in the consolidated statements of income and comprehensive income were as follows:

	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
SALES AND OTHER OPERATING REVENUES
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	93,198		$	81,463		$	246,669		$	179,456
Other Regions (1)	495,982			460,729			992,574			1,009,162
Subtotal	589,180			542,192			1,239,243			1,188,618
Other Tobacco Operations (2)	79,591			42,400			181,945			127,775
Consolidated sales and other operating revenues	$	668,771		$	584,592		$	1,421,188		$	1,316,393
OPERATING INCOME
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	1,025		$	5,750		$	21,404		$	12,949
Other Regions (1)	81,074			61,318			96,399			87,673
Subtotal	82,099			67,068			117,803			100,622
Other Tobacco Operations (2)	5,781			1,083			10,215			2,136
Segment operating income	87,880			68,151			128,018			102,758
Deduct: Equity in pretax earnings of unconsolidated affiliates (3)	(4,495		)	(2,326		)	(5,625		)	(2,556		)
Restructuring and impairment costs (4)	(178		)	—			(3,860		)	(2,389		)
Add: Other income (5)	—			3,390			—			3,390
Consolidated operating income	$	83,207		$	69,215		$	118,533		$	101,203

⁽¹⁾  Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

⁽²⁾  Includes Dark Air-Cured, Special Services, and Oriental, as well as inter-company eliminations. Sales and other operating revenues for this reportable segment include limited amounts for Oriental because its financial results consist principally of equity in the pretax earnings of an unconsolidated affiliate.

⁽³⁾  Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

⁽⁴⁾  Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

⁽⁵⁾  Other income represents a gain from remeasuring to fair value the Company's original 50% ownership interest in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner. This item is excluded from segment operating income, but is included in consolidated operating income in the consolidated statements of income and comprehensive income.

XML

Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)

9 Months Ended

Dec. 31, 2016

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Income (Loss), Net of Tax

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in the accumulated balances for each component of accumulated other comprehensive income (loss) attributable to the Company for the nine months ended December 31, 2016 and 2015:

	Nine Months Ended December 31,
(in thousands of dollars)	2016			2015
Foreign currency translation:
Balance at beginning of year	$	(26,992	)	$	(31,138	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax benefit of $4,408 and $319)	(8,186		)	(508		)
Less: Net loss on foreign currency translation attributable to noncontrolling interests	645			465
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(7,541		)	(43		)
Balance at end of period	$	(34,533	)	$	(31,181	)
Foreign currency hedge:
Balance at beginning of year	$	675		$	(1,834	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $1,006 and $(464))	(1,868		)	861
Reclassification of (gain) loss to earnings (net of tax benefit of $(304) and $(188))(1)	564			352
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(1,304		)	1,213
Balance at end of period	$	(629	)	$	(621	)
Interest rate hedge:
Balance at beginning of year	$	(6,997	)	$	(1,982	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(2,969) and $885)	5,514			(1,643		)
Reclassification of loss to earnings (net of tax benefit of $(1,098) and $(1,402))(2)	2,038			2,603
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	7,552			960
Balance at end of period	$	555		$	(1,022	)
Pension and other postretirement benefit plans:
Balance at beginning of year	$	(39,036	)	$	(40,040	)
Other comprehensive income (loss) attributable to Universal Corporation:
Amortization included in earnings (net of tax benefit of $(881) and $(1,257)) (3)	1,920			2,425
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,920			2,425
Balance at end of period	$	(37,116	)	$	(37,615	)
Total accumulated other comprehensive loss at end of period	$	(71,723	)	$	(70,439	)

⁽¹⁾ Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 7 for additional information.

⁽²⁾   Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the underlying debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 7 for additional information.

⁽³⁾ This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 9 for additional information.

XML

Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries

9 Months Ended

Dec. 31, 2016

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]

Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries

CHANGES IN SHAREHOLDERS' EQUITY AND NONCONTROLLING INTERESTS IN SUBSIDIARIES

A reconciliation of the changes in Universal Corporation shareholders’ equity and noncontrolling interests in subsidiaries for the nine months ended December 31, 2016 and 2015 is as follows:

	Nine Months Ended December 31, 2016									Nine Months Ended December 31, 2015
(in thousands of dollars)	Universal Corporation			Non-controlling Interests			Total			Universal Corporation			Non-controlling Interests			Total
Balance at beginning of year	$	1,414,222		$	38,840		$	1,453,062		$	1,362,725		$	34,369		$	1,397,094
Changes in preferred stock
Conversion of Series B 6.75% convertible perpetual preferred stock to common stock	(107,550		)	—			(107,550		)	—			—			—
Changes in common stock
Conversion of Series B 6.75% convertible perpetual preferred stock to common stock	107,550			—			107,550			—			—			—
Accrual of stock-based compensation	4,766			—			4,766			4,157			—			4,157
Withholding of shares from stock-based compensation for grantee income taxes	(2,256		)	—			(2,256		)	(3,737		)	—			(3,737		)
Dividend equivalents on RSUs	503			—			503			519			—			519
Changes in retained earnings
Net income	73,435			2,621			76,056			61,052			4,502			65,554
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock	(11,061		)	—			(11,061		)	(11,061		)	—			(11,061		)
Common stock	(37,787		)	—			(37,787		)	(35,641		)	—			(35,641		)
Dividend equivalents on RSUs	(503		)	—			(503		)	(519		)	—			(519		)
Other comprehensive income (loss)	627			(645		)	(18		)	4,555			(465		)	4,090
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders	—			(1,260		)	(1,260		)	—			(1,260		)	(1,260		)
Balance at end of period	$	1,441,946		$	39,556		$	1,481,502		$	1,382,050		$	37,146		$	1,419,196

XML

Earnings Per Share (Tables)

9 Months Ended

Dec. 31, 2016

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted earnings per share:

	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands, except share and per share data)	2016			2015			2016			2015
Basic Earnings Per Share
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$	53,647		$	44,534		$	73,435		$	61,052
Less: Dividends on convertible perpetual preferred stock	(3,687		)	(3,687		)	(11,061		)	(11,061		)
Earnings available to Universal Corporation common shareholders for calculation of basic earnings per share	49,960			40,847			62,374			49,991
Denominator for basic earnings per share
Weighted average shares outstanding	22,982,473			22,717,043			22,831,717			22,671,943
Basic earnings per share	$	2.17		$	1.80		$	2.73		$	2.20
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$	49,960		$	40,847		$	62,374		$	49,991
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	3,687			3,687			11,061			—
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	53,647			44,534			73,435			49,991
Denominator for diluted earnings per share
Weighted average shares outstanding	22,982,473			22,717,043			22,831,717			22,671,943
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock	4,693,155			4,857,262			4,816,904			—
Employee share-based awards	320,955			280,603			318,594			285,107
Denominator for diluted earnings per share	27,996,583			27,854,908			27,967,215			22,957,050
Diluted earnings per share	$	1.92		$	1.60		$	2.63		$	2.18

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company had the following potentially dilutive securities (stock appreciation rights) outstanding for the nine months ended December 31, 2016 and 2015 that were not included in the computation of diluted earnings per share because their exercise price exceeded the market price of the Company's common stock, and thus their effect would have been antidilutive:

	Nine Months Ended December 31,
	2016		2015
Potentially dilutive securities	122,200		133,600
Weighted-average exercise price	$	62.66	$	62.66

XML

Derivatives And Hedging Activities (Tables)

9 Months Ended

Dec. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Notional Amount of Forward Contracts

The aggregate U.S. dollar notional amount of forward contracts entered for these purposes during the first nine months of fiscal years 2017 and 2016 was as follows:

	Nine Months Ended December 31,
(in millions of dollars)	2016		2015
Tobacco purchases	$	9.7	$	19.8
Processing costs	2.7		5.6
Total	$	12.4	$	25.4

Effect Of Derivative Financial Instruments On The Consolidated Statements Of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements of income for the three- and nine-month periods ended December 31, 2016 and 2015:

	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	10,876		$	3,529		$	8,484		$	(2,527	)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	(987	)	$	(1,328	)	$	(3,135	)	$	(4,004	)
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings	$	—		$	—		$	—		$	—
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Floating rate interest payments on term loan
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	—		$	—		$	453		$	1,283
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	102		$	362		$	770		$	720
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings	$	—		$	—		$	246		$	745
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges - Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings	$	(1,576	)	$	(2,366	)	$	(2,932	)	$	6,014
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses

Effect Of Derivative Financial Instruments On The Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets at December 31, 2016 and 2015, and March 31, 2016:

	Derivatives in a Fair Value Asset Position							Derivatives in a Fair Value Liability Position
	Balance Sheet Location	Fair Value as of						Balance Sheet Location	Fair Value as of
(in thousands of dollars)		December 31, 2016		December 31, 2015		March 31, 2016			December 31, 2016		December 31, 2015		March 31, 2016
Derivatives Designated as Hedging Instruments
Interest rate swap agreements	Other non-current assets	$	853	$	—	$	—	Other long-term liabilities	$	—	$	1,573	$	10,766
Forward foreign currency exchange contracts	Other current assets	—		—		475		Accounts payable and accrued expenses	—		—		—
Total		$	853	$	—	$	475		$	—	$	1,573	$	10,766
Derivatives Not Designated as Hedging Instruments
Forward foreign currency exchange contracts	Other current assets	$	4	$	540	$	297	Accounts payable and accrued expenses	$	1,229	$	90	$	5
Total		$	4	$	540	$	297		$	1,229	$	90	$	5

XML

Fair Value Measurements (Tables)

9 Months Ended

Dec. 31, 2016

Fair Value Disclosures [Abstract]

Financial Assets And Liabilities Measured At Fair Value On Recurring Basis

At December 31, 2016 and 2015, and at March 31, 2016, the Company had certain financial assets and financial liabilities that were required to be measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified based on how their values were determined under the fair value hierarchy or the NAV practical expedient:

	December 31, 2016
			Fair Value Hierarchy
(in thousands of dollars)	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	241,991	$	—	$	—	$	—	$	241,991
Trading securities associated with deferred compensation plans	—		17,210		—		—		17,210
Interest rate swap agreements	—		—		853		—		853
Forward foreign currency exchange contracts	—		—		4		—		4
Total financial assets measured and reported at fair value	$	241,991	$	17,210	$	857	$	—	$	260,058
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,844	$	1,844
Forward foreign currency exchange contracts	—		—		1,229		—		1,229
Total financial liabilities measured and reported at fair value	$	—	$	—	$	1,229	$	1,844	$	3,073

	December 31, 2015
			Fair Value Hierarchy
(in thousands of dollars)	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	26,578	$	—	$	—	$	—	$	26,578
Trading securities associated with deferred compensation plans	—		18,907		—		—		18,907
Forward foreign currency exchange contracts	—		—		540		—		540
Total financial assets measured and reported at fair value	$	26,578	$	18,907	$	540	$	—	$	46,025
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,469	$	1,469
Interest rate swap agreements	—		—		1,573		—		1,573
Forward foreign currency exchange contracts	—		—		90		—		90
Total financial liabilities measured and reported at fair value	$	—	$	—	$	1,663	$	1,469	$	3,132

	March 31, 2016
			Fair Value Hierarchy
(in thousands of dollars)	NAV		Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	116,618	$	—	$	—	$	—	$	116,618
Trading securities associated with deferred compensation plans	—		17,817		—		—		17,817
Forward foreign currency exchange contracts	—		—		772		—		772
Total financial assets measured and reported at fair value	$	116,618	$	17,817	$	772	$	—	$	135,207
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	—	$	1,628	$	1,628
Interest rate swap agreements	—		—		10,766		—		10,766
Forward foreign currency exchange contracts	—		—		5		—		5
Total financial liabilities measured and reported at fair value	$	—	$	—	$	10,771	$	1,628	$	12,399

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 3) for the nine months ended December 31, 2016 and 2015 is provided below.

	Nine Months Ended December 31,
(in thousands of dollars)	2016			2015
Balance at beginning of year	$	1,628		$	1,674
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from portfolio)	(1,848		)	(1,826		)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,856			1,851
Change in discount rate and estimated collection period	55			76
Currency remeasurement	153			(306		)
Balance at end of period	$	1,844		$	1,469

XML

Pension And Other Postretirement Benefit Plans (Tables)

9 Months Ended

Dec. 31, 2016

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Components of Company's Net Periodic Benefit Cost

The components of the Company’s net periodic benefit cost were as follows:

	Pension Benefits						Other Postretirement Benefits
	Three Months Ended December 31,						Three Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
Service cost	$	1,343		$	1,469		$	73		$	106
Interest cost	2,453			2,345			378			387
Expected return on plan assets	(3,584		)	(3,574		)	(11		)	(15		)
Net amortization and deferral	843			1,201			(100		)	(44		)
Net periodic benefit cost	$	1,055		$	1,441		$	340		$	434

	Pension Benefits						Other Postretirement Benefits
	Nine Months Ended December 31,						Nine Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
Service cost	$	4,063		$	4,431		$	220		$	320
Interest cost	7,389			7,038			1,136			1,186
Expected return on plan assets	(10,762		)	(10,727		)	(33		)	(45		)
Net amortization and deferral	2,519			3,599			(300		)	(132		)
Net periodic benefit cost	$	3,209		$	4,341		$	1,023		$	1,329

XML

Stock-Based Compensation (Tables)

9 Months Ended

Dec. 31, 2016

Share-based Compensation [Abstract]

Stock-Based Awards Issued During The Period

During the nine-month periods ended December 31, 2016 and 2015, Universal issued the following stock-based awards, representing the regular annual grants to officers and outside directors of the Company:

	Nine Months Ended December 31,
	2016		2015
RSUs:
Number granted	63,425		67,750
Grant date fair value	$	55.93	$	52.10
PSAs:
Number granted	54,675		57,750
Grant date fair value	$	49.17	$	45.06

XML

Operating Segments (Tables)

9 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Operating Results For The Company's Reportable Segments

Operating results for the Company’s reportable segments for each period presented in the consolidated statements of income and comprehensive income were as follows:

	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands of dollars)	2016			2015			2016			2015
SALES AND OTHER OPERATING REVENUES
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	93,198		$	81,463		$	246,669		$	179,456
Other Regions (1)	495,982			460,729			992,574			1,009,162
Subtotal	589,180			542,192			1,239,243			1,188,618
Other Tobacco Operations (2)	79,591			42,400			181,945			127,775
Consolidated sales and other operating revenues	$	668,771		$	584,592		$	1,421,188		$	1,316,393
OPERATING INCOME
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	1,025		$	5,750		$	21,404		$	12,949
Other Regions (1)	81,074			61,318			96,399			87,673
Subtotal	82,099			67,068			117,803			100,622
Other Tobacco Operations (2)	5,781			1,083			10,215			2,136
Segment operating income	87,880			68,151			128,018			102,758
Deduct: Equity in pretax earnings of unconsolidated affiliates (3)	(4,495		)	(2,326		)	(5,625		)	(2,556		)
Restructuring and impairment costs (4)	(178		)	—			(3,860		)	(2,389		)
Add: Other income (5)	—			3,390			—			3,390
Consolidated operating income	$	83,207		$	69,215		$	118,533		$	101,203

⁽¹⁾  Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

⁽²⁾  Includes Dark Air-Cured, Special Services, and Oriental, as well as inter-company eliminations. Sales and other operating revenues for this reportable segment include limited amounts for Oriental because its financial results consist principally of equity in the pretax earnings of an unconsolidated affiliate.

⁽³⁾  Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

⁽⁴⁾  Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

⁽⁵⁾  Other income represents a gain from remeasuring to fair value the Company's original 50% ownership interest in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner. This item is excluded from segment operating income, but is included in consolidated operating income in the consolidated statements of income and comprehensive income.

XML

Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Dec. 31, 2016

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table summarizes the changes in the accumulated balances for each component of accumulated other comprehensive income (loss) attributable to the Company for the nine months ended December 31, 2016 and 2015:

	Nine Months Ended December 31,
(in thousands of dollars)	2016			2015
Foreign currency translation:
Balance at beginning of year	$	(26,992	)	$	(31,138	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax benefit of $4,408 and $319)	(8,186		)	(508		)
Less: Net loss on foreign currency translation attributable to noncontrolling interests	645			465
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(7,541		)	(43		)
Balance at end of period	$	(34,533	)	$	(31,181	)
Foreign currency hedge:
Balance at beginning of year	$	675		$	(1,834	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $1,006 and $(464))	(1,868		)	861
Reclassification of (gain) loss to earnings (net of tax benefit of $(304) and $(188))(1)	564			352
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(1,304		)	1,213
Balance at end of period	$	(629	)	$	(621	)
Interest rate hedge:
Balance at beginning of year	$	(6,997	)	$	(1,982	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(2,969) and $885)	5,514			(1,643		)
Reclassification of loss to earnings (net of tax benefit of $(1,098) and $(1,402))(2)	2,038			2,603
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	7,552			960
Balance at end of period	$	555		$	(1,022	)
Pension and other postretirement benefit plans:
Balance at beginning of year	$	(39,036	)	$	(40,040	)
Other comprehensive income (loss) attributable to Universal Corporation:
Amortization included in earnings (net of tax benefit of $(881) and $(1,257)) (3)	1,920			2,425
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,920			2,425
Balance at end of period	$	(37,116	)	$	(37,615	)
Total accumulated other comprehensive loss at end of period	$	(71,723	)	$	(70,439	)

⁽¹⁾ Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 7 for additional information.

⁽²⁾   Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the underlying debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 7 for additional information.

⁽³⁾ This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 9 for additional information.

XML

Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries (Tables)

9 Months Ended

Dec. 31, 2016

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]

Reconciliation Of Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries

A reconciliation of the changes in Universal Corporation shareholders’ equity and noncontrolling interests in subsidiaries for the nine months ended December 31, 2016 and 2015 is as follows:

	Nine Months Ended December 31, 2016									Nine Months Ended December 31, 2015
(in thousands of dollars)	Universal Corporation			Non-controlling Interests			Total			Universal Corporation			Non-controlling Interests			Total
Balance at beginning of year	$	1,414,222		$	38,840		$	1,453,062		$	1,362,725		$	34,369		$	1,397,094
Changes in preferred stock
Conversion of Series B 6.75% convertible perpetual preferred stock to common stock	(107,550		)	—			(107,550		)	—			—			—
Changes in common stock
Conversion of Series B 6.75% convertible perpetual preferred stock to common stock	107,550			—			107,550			—			—			—
Accrual of stock-based compensation	4,766			—			4,766			4,157			—			4,157
Withholding of shares from stock-based compensation for grantee income taxes	(2,256		)	—			(2,256		)	(3,737		)	—			(3,737		)
Dividend equivalents on RSUs	503			—			503			519			—			519
Changes in retained earnings
Net income	73,435			2,621			76,056			61,052			4,502			65,554
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock	(11,061		)	—			(11,061		)	(11,061		)	—			(11,061		)
Common stock	(37,787		)	—			(37,787		)	(35,641		)	—			(35,641		)
Dividend equivalents on RSUs	(503		)	—			(503		)	(519		)	—			(519		)
Other comprehensive income (loss)	627			(645		)	(18		)	4,555			(465		)	4,090
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders	—			(1,260		)	(1,260		)	—			(1,260		)	(1,260		)
Balance at end of period	$	1,441,946		$	39,556		$	1,481,502		$	1,382,050		$	37,146		$	1,419,196

XML

Accounting Pronouncements Accounting Pronouncements (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Accounting Standards Update 2015-03 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Unamortized Debt Issuance Expense	$ 1.8	$ 1.6

XML

Guarantees, Other Contingent Liabilities, And Other Matters (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended		12 Months Ended
	Jan. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2017	Jan. 09, 2017	Mar. 31, 2016
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Face amount of guarantee including unpaid accrued interest		$ 35,000	$ 27,000			$ 13,000
Fair value of the guarantees		1,844	1,469			1,628
Other contingent liabilities		2,000
Advances to suppliers current and non-current		125,000	116,000			134,000
Valuation allowance amount related to advances to suppliers		30,000	28,000			29,000
Net provision for losses (recoveries) on advances and guaranteed loans to suppliers		414	(1,026)
Aggregate balance of recoverable value added tax credits		41,000	51,000			52,000
Valuation allowance on recoverable value added tax credits		$ 11,000	19,000			$ 19,000
Percentage of outstanding convertible perpetual preferred stock converted		50.80%
Preferred stock dividends		$ 11,061	$ 11,061
Conversion of convertible perpetual preferred stock [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Preferred stock, shares outstanding					107,418
Payments for repurchase of convertible perpetual preferred stock	$ 178,400
Preferred stock dividends				$ 15,000
Repurchase of stock, retained earnings				$ 74,400
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Preferred stock, shares converted to common stock		111,072
Non-cash reclassification of preferred stock converted		$ 107,600
Common Stock [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Conversion of Stock, Shares Issued		2,487,118
Santa Catarina [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Brazil audit assessment for tax, penalties, and interest on recoverable value added tax credits		$ 15,000
Reduced Brazil audit assessment for tax, penalties, and interest on recoverable value added tax credits		14,000
Santa Catarina [Member] | Minimum [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment		0
Santa Catarina [Member] | Maximum [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment		14,000
Parana [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Brazil audit assessment for tax, penalties, and interest on recoverable value added tax credits		17,000
Reduced Brazil audit assessment for tax, penalties, and interest on recoverable value added tax credits		5,000
Parana [Member] | Minimum [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment		0
Parana [Member] | Maximum [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment		$ 5,000

XML

Restructuring Costs Restructuring costs (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Restructuring Costs [Line Items]
Restructuring and impairment costs	[1]	$ 178	$ 0	$ 3,860	$ 2,389

[1] Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

XML

Earnings Per Share Earnings Per Share (Narrative) (Details)	9 Months Ended
	Dec. 31, 2016 shares
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Preferred stock, shares converted to common stock	111,072
Common Stock [Member]
Conversion of Stock, Shares Issued	2,487,118

XML

Earnings Per Share (Computation Of Basic And Diluted Earnings (Loss) Per Share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$ 53,647	$ 44,534	$ 73,435	$ 61,052
Less: Dividends on convertible perpetual preferred stock	(3,687)	(3,687)	(11,061)	(11,061)
Earnings available to Universal Corporation common shareholders	$ 49,960	$ 40,847	$ 62,374	$ 49,991
Denominator for basic earnings per share
Weighted average shares outstanding	22,982,473	22,717,043	22,831,717	22,671,943
Basic earnings per share	$ 2.17	$ 1.80	$ 2.73	$ 2.20
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$ 49,960	$ 40,847	$ 62,374	$ 49,991
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	3,687	3,687	11,061	0
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	$ 53,647	$ 44,534	$ 73,435	$ 49,991
Denominator for diluted earnings per share:
Weighted average shares outstanding	22,982,473	22,717,043	22,831,717	22,671,943
Convertible perpetual preferred stock	4,693,155	4,857,262	4,816,904	0
Employee share-based awards	320,955	280,603	318,594	285,107
Denominator for diluted earnings per share	27,996,583	27,854,908	27,967,215	22,957,050
Diluted earnings per share	$ 1.92	$ 1.60	$ 2.63	$ 2.18

XML

Earnings Per Share (Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) shares in Thousands	9 Months Ended
	Dec. 31, 2016 shares	Dec. 31, 2015 shares
Earnings Per Share [Abstract]
Potentially dilutive securities	122,200	133,600
Weighted-average exercise price	62.66	62.66

XML

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Line Items]
Effective income tax rate	32.00%	32.00%	33.00%	29.00%
Federal statutory income tax rate	35.00%	35.00%	35.00%	35.00%

XML

Derivatives And Hedging Activities (Narrative) (Details) - USD ($) $ in Millions	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Derivative [Line Items]
Net unrealized gain on foreign currency derivatives designated as cash flow hedges	$ 0.2
Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional amount of derivative contracts	23.4	$ 56.8
Cash Flow Hedging [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Notional amount of derivative contracts	$ 370.0

XML

Derivatives And Hedging Activities Notional Amount of Forward Contracts (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Forward Foreign Currency Exchange Contract [Member]
Derivative [Line Items]
Notional amount of derivative contracts	$ 12.4	$ 25.4
Forward contracts related to tobacco purchase | Derivatives Designated As Hedges [Member]
Derivative [Line Items]
Notional amount of derivative contracts	9.7	19.8
Forward contracts related to tobacco processing costs | Derivatives Not Designated As Hedges [Member]
Derivative [Line Items]
Notional amount of derivative contracts	$ 2.7	$ 5.6

XML

Derivatives And Hedging Activities (Effect Of Derivative Financial Instruments On The Consolidated Statements Of Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Derivatives Designated As Hedges [Member] | Interest Rate Swap Agreements [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recorded in accumulated other comprehensive loss	$ 10,876	$ 3,529	$ 8,484	$ (2,527)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	(987)	(1,328)	(3,135)	(4,004)
Derivatives Designated As Hedges [Member] | Interest Rate Swap Agreements [Member] | Selling, General And Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in earnings from ineffective portion and early de-designation of cash flow hedges	0	0	0	0
Derivatives Designated As Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member] | Cost Of Goods Sold [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recorded in accumulated other comprehensive loss	0	0	453	1,283
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	102	362	770	720
Derivatives Designated As Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member] | Selling, General And Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in earnings from ineffective portion and early de-designation of cash flow hedges	0	0	246	745
Derivatives Not Designated As Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member] | Selling, General And Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in earnings	$ (1,576)	$ (2,366)	$ (2,932)	$ 6,014

XML

Derivatives And Hedging Activities (Effect Of Derivative Financial Instruments On The Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Derivative [Line Items]
Derivatives in a Fair Value Asset Position Designated as Hedging Instruments	$ 853	$ 475	$ 0
Derivatives in a Fair Value Liability Position Designated as Hedging Instruments	0	10,766	1,573
Derivatives in a Fair Value Asset Position Not Designated as Hedging Instruments	4	297	540
Derivatives in a Fair Value Liability Position Not Designated as Hedging Instruments	1,229	5	90
Interest Rate Swap Agreements [Member] | Other Non-Current Assets [Member]
Derivative [Line Items]
Derivatives in a Fair Value Asset Position Designated as Hedging Instruments	853	0	0
Interest Rate Swap Agreements [Member] | Other Long-Term Liabilities [Member]
Derivative [Line Items]
Derivatives in a Fair Value Liability Position Designated as Hedging Instruments	0	10,766	1,573
Forward Foreign Currency Exchange Contract [Member] | Other Current Assets [Member]
Derivative [Line Items]
Derivatives in a Fair Value Asset Position Designated as Hedging Instruments	0	475	0
Derivatives in a Fair Value Asset Position Not Designated as Hedging Instruments	4	297	540
Forward Foreign Currency Exchange Contract [Member] | Accounts Payable and Accrued Expenses [Member]
Derivative [Line Items]
Derivatives in a Fair Value Liability Position Designated as Hedging Instruments	0	0	0
Derivatives in a Fair Value Liability Position Not Designated as Hedging Instruments	$ 1,229	$ 5	$ 90

XML

Fair Value Measurements (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Long-term Debt, Fair Value	$ 370	$ 370	$ 370

XML

Fair Value Measurements (Financial Assets And Liabilities Measured At Fair Value On Recurring Basis) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Assets:
Money market funds	$ 241,991	$ 116,618	$ 26,578
Trading securities associated with deferred compensation plans	17,210	17,817	18,907
Interest Rate Derivative Assets, at Fair Value	853
Forward foreign currency exchange contracts	4	772	540
Total financial assets measured and reported at fair value	260,058	135,207	46,025
Liabilities:
Guarantees of bank loans to tobacco growers	1,844	1,628	1,469
Interest rate swap agreements		10,766	1,573
Forward foreign currency exchange contracts	1,229	5	90
Total financial liabilities measured and reported at fair value	3,073	12,399	3,132
Net Asset Value (NAV) [Member]
Assets:
Money market funds	241,991	116,618	26,578
Trading securities associated with deferred compensation plans	0	0	0
Interest Rate Derivative Assets, at Fair Value	0
Forward foreign currency exchange contracts	0	0	0
Total financial assets measured and reported at fair value	241,991	116,618	26,578
Liabilities:
Guarantees of bank loans to tobacco growers	0	0	0
Interest rate swap agreements		0	0
Forward foreign currency exchange contracts	0	0	0
Total financial liabilities measured and reported at fair value	0	0	0
Level 1 [Member]
Assets:
Money market funds	0	0	0
Trading securities associated with deferred compensation plans	17,210	17,817	18,907
Interest Rate Derivative Assets, at Fair Value	0
Forward foreign currency exchange contracts	0	0	0
Total financial assets measured and reported at fair value	17,210	17,817	18,907
Liabilities:
Guarantees of bank loans to tobacco growers	0	0	0
Interest rate swap agreements		0	0
Forward foreign currency exchange contracts	0	0	0
Total financial liabilities measured and reported at fair value	0	0	0
Level 2 [Member]
Assets:
Money market funds	0	0	0
Trading securities associated with deferred compensation plans	0	0	0
Interest Rate Derivative Assets, at Fair Value	853
Forward foreign currency exchange contracts	4	772	540
Total financial assets measured and reported at fair value	857	772	540
Liabilities:
Guarantees of bank loans to tobacco growers	0	0	0
Interest rate swap agreements		10,766	1,573
Forward foreign currency exchange contracts	1,229	5	90
Total financial liabilities measured and reported at fair value	1,229	10,771	1,663
Level 3 [Member]
Assets:
Money market funds	0	0	0
Trading securities associated with deferred compensation plans	0	0	0
Interest Rate Derivative Assets, at Fair Value	0
Forward foreign currency exchange contracts	0	0	0
Total financial assets measured and reported at fair value	0	0	0
Liabilities:
Guarantees of bank loans to tobacco growers	1,844	1,628	1,469
Interest rate swap agreements		0	0
Forward foreign currency exchange contracts	0	0	0
Total financial liabilities measured and reported at fair value	$ 1,844	$ 1,628	$ 1,469

XML

Fair Value Measurements (Reconciliation Of Change In Balance Of Financial Liability For Guarantees Of Bank Loans To Tobacco Growers) (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Balance at beginning of year	$ 1,628	$ 1,674
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from portfolio)	(1,848)	(1,826)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,856	1,851
Change in discount rate and estimated collection period	55	76
Currency remeasurement	153	(306)
Balance at end of period	$ 1,844	$ 1,469

XML

Pension And Other Postretirement Benefit Plans Pension And Other Postretirement Benefit Plans (Narrative) (Details) $ in Millions	9 Months Ended
	Dec. 31, 2016 USD ($)
Pension and Other Postretirement Benefits [Line Items]
Contributions to qualified and non-qualified pension plans	$ 10.4
Expected additional contributions in the current fiscal year	$ 0.6

XML

Pension And Other Postretirement Benefit Plans (Components Of Company's Net Periodic Benefit Cost) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 1,343	$ 1,469	$ 4,063	$ 4,431
Interest cost	2,453	2,345	7,389	7,038
Expected return on plan assets	(3,584)	(3,574)	(10,762)	(10,727)
Net amortization and deferral	843	1,201	2,519	3,599
Net periodic benefit cost	1,055	1,441	3,209	4,341
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	73	106	220	320
Interest cost	378	387	1,136	1,186
Expected return on plan assets	(11)	(15)	(33)	(45)
Net amortization and deferral	(100)	(44)	(300)	(132)
Net periodic benefit cost	$ 340	$ 434	$ 1,023	$ 1,329

XML

Stock-Based Compensation (Narrative) (Details) - USD ($) $ in Millions	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 4.8	$ 4.2
Expected stock based compensation for remaining fiscal year	$ 1.1
Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Description of award vesting rights for SARs	vest in equal one-third tranches one, two, and three years after the grant date
Expiration period following grant date	10 years
Expiration period following grantee retirement	3 years
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	5 years
Performance Share Awards (PSAs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Minimum [Member] | Performance Share Awards (PSAs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of award grant paid	0.00%
Maximum [Member] | Performance Share Awards (PSAs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of award grant paid	150.00%
Outside Directors [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years

XML

Stock-Based Compensation (Stock-Based Awards Issued During The Period) (Details) - $ / shares	9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number granted	63,425	67,750
Grant date fair value	$ 55.93	$ 52.10
Performance Share Awards (PSAs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number granted	54,675	57,750
Grant date fair value	$ 49.17	$ 45.06

XML

Operating Segments (Operating Results For The Company's Reportable Segments) (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Segment Reporting Information [Line Items]
Sales and other operating revenues		$ 668,771	$ 584,592	$ 1,421,188	$ 1,316,393
Deduct: Equity in pretax earnings of unconsolidated affiliates	[1]	(4,495)	(2,326)	(5,625)	(2,556)
Restructuring and impairment costs	[2]	(178)	0	(3,860)	(2,389)
Other Income	[3]	0	3,390	0	3,390
Consolidated operating income		83,207	69,215	118,533	101,203
Flue-Cured And Burley Leaf Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues		589,180	542,192	1,239,243	1,188,618
Consolidated operating income		82,099	67,068	117,803	100,622
Flue-Cured And Burley Leaf Tobacco Operations [Member] | North America [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues		93,198	81,463	246,669	179,456
Consolidated operating income		1,025	5,750	21,404	12,949
Flue-Cured And Burley Leaf Tobacco Operations [Member] | Other Regions [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues	[4]	495,982	460,729	992,574	1,009,162
Consolidated operating income	[4]	81,074	61,318	96,399	87,673
Operating Segments [Member]
Segment Reporting Information [Line Items]
Consolidated operating income		87,880	68,151	128,018	102,758
Other Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues	[5]	79,591	42,400	181,945	127,775
Consolidated operating income	[5]	$ 5,781	$ 1,083	$ 10,215	$ 2,136

[1] Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

[2] Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

[3] Other income represents a gain from remeasuring to fair value the Company's original 50% ownership interest in Procesadora Unitab, S.A., a tobacco processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner. This item is excluded from segment operating income, but is included in consolidated operating income in the consolidated statements of income and comprehensive income.

[4] Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

[5] Includes Dark Air-Cured, Special Services, and Oriental, as well as inter-company eliminations. Sales and other operating revenues for this reportable segment include limited amounts for Oriental because its financial results consist principally of equity in the pretax earnings of an unconsolidated affiliate.

XML

Accumulated Other Comprehensive Income (Loss) (Narrative) (Details) - USD ($) $ in Thousands		9 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2016
Other Comprehensive Income (Loss), Tax [Abstract]
Accumulated other comprehensive loss		$ (71,723)	$ (70,439)	$ (72,350)
Accumulated Translation Adjustment [Member]
Foreign currency translation: [Abstract]
Balance at beginning of year		(26,992)	(31,138)
Net gain (loss) on foreign currency translation, net of income taxes		(8,186)	(508)
Less: Net loss on foreign currency translation attributable to noncontrolling interests		645	465
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		(7,541)	(43)
Balance at end of period		(34,533)	(31,181)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on net gain (loss) on foreign currency translation		4,408	319
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Forward Foreign Currency Exchange Contract [Member]
Cash flow hedges: [Abstract]
Balance at beginning of year		675	(1,834)
Net gain (loss) on derivative instruments, net of income taxes		(1,868)	861
Reclassifications to earnings, net of income taxes	[1]	564	352
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		(1,304)	1,213
Balance at end of period		(629)	(621)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on net gain (loss) on derivative instruments		1,006	(464)
Taxes on reclassifications to net income		(304)	(188)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Interest Rate Swap [Member]
Cash flow hedges: [Abstract]
Balance at beginning of year		(6,997)	(1,982)
Net gain (loss) on derivative instruments, net of income taxes		5,514	(1,643)
Reclassifications to earnings, net of income taxes	[2]	2,038	2,603
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		7,552	960
Balance at end of period		555	(1,022)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on net gain (loss) on derivative instruments		(2,969)	885
Taxes on reclassifications to net income		(1,098)	(1,402)
Accumulated Defined Benefit Plans Adjustment [Member]
Pension and other postretirement benefit plan: [Abstract]
Balance at beginning of year		(39,036)	(40,040)
Amortization included in earnings, net of income taxes	[3]	1,920	2,425
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		1,920	2,425
Balance at end of period		(37,116)	(37,615)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on amortization included in net income		$ (881)	$ (1,257)

[1] Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 7 for additional information.

[2] Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the underlying debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 7 for additional information.

[3] This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 9 for additional information.

XML

Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries (Reconciliation Of Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Schedule of Capitalization, Equity [Line Items]
Total stockholders' equity attributable to parent, beginning balance			$ 1,414,222
Noncontrolling interests in subsidiaries, beginning balance			38,840
Total shareholders' equity, beginning balance			1,453,062	$ 1,397,094
Non-cash classification of common stock converted			107,550	0
Accrual of stock-based compensation			4,766	4,157
Withholding of shares from stock-based compensation for grantee income taxes (SARs, RSUs, and PSAs)			(2,256)	(3,737)
Dividend equivalents on RSUs			503	519
Net income (loss) attributable to parent	$ 53,647	$ 44,534	73,435	61,052
Net income attributable to noncontrolling interest	3,415	2,081	2,621	4,502
Net (income) loss	57,062	46,615	76,056	65,554
Series B 6.75% convertible perpetual preferred stock dividends declared			(11,061)	(11,061)
Common stock dividends declared			(37,787)	(35,641)
Dividend equivalents on RSUs			(503)	(519)
Dividends paid to noncontrolling interests			1,260	1,260
Other comprehensive income (loss)			(18)	4,090
Total stockholders' equity attributable to parent, ending balance	1,441,946	1,382,050	1,441,946	1,382,050
Noncontrolling interest in subsidiaries, ending balance	39,556	37,146	39,556	37,146
Total shareholders' equity, ending balance	1,481,502	1,419,196	1,481,502	1,419,196
Universal Corporation [Member]
Schedule of Capitalization, Equity [Line Items]
Total stockholders' equity attributable to parent, beginning balance			1,414,222	1,362,725
Non-cash classification of common stock converted			107,550	0
Accrual of stock-based compensation			4,766	4,157
Withholding of shares from stock-based compensation for grantee income taxes (SARs, RSUs, and PSAs)			(2,256)	(3,737)
Dividend equivalents on RSUs			503	519
Net income (loss) attributable to parent			73,435	61,052
Series B 6.75% convertible perpetual preferred stock dividends declared			(11,061)	(11,061)
Common stock dividends declared			(37,787)	(35,641)
Dividend equivalents on RSUs			(503)	(519)
Other comprehensive income (loss) attributable to parent			627	4,555
Dividends paid to noncontrolling interests			0	0
Total stockholders' equity attributable to parent, ending balance	1,441,946	1,382,050	1,441,946	1,382,050
Noncontrolling Interests [Member]
Schedule of Capitalization, Equity [Line Items]
Noncontrolling interests in subsidiaries, beginning balance			38,840	34,369
Non-cash classification of common stock converted			0	0
Accrual of stock-based compensation			0	0
Withholding of shares from stock-based compensation for grantee income taxes (SARs, RSUs, and PSAs)			0	0
Dividend equivalents on RSUs			0	0
Net income attributable to noncontrolling interest			2,621	4,502
Series B 6.75% convertible perpetual preferred stock dividends declared			0	0
Common stock dividends declared			0	0
Dividend equivalents on RSUs			0	0
Other comprehensive income (loss) attributable to noncontrolling interest			(645)	(465)
Dividends paid to noncontrolling interests			1,260	1,260
Noncontrolling interest in subsidiaries, ending balance	$ 39,556	$ 37,146	39,556	37,146
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Schedule of Capitalization, Equity [Line Items]
Non-cash reclassification of preferred stock converted			(107,550)	0
Series B 6.75% Convertible Perpetual Preferred Stock [Member] | Universal Corporation [Member]
Schedule of Capitalization, Equity [Line Items]
Non-cash reclassification of preferred stock converted			(107,550)	0
Series B 6.75% Convertible Perpetual Preferred Stock [Member] | Noncontrolling Interests [Member]
Schedule of Capitalization, Equity [Line Items]
Non-cash reclassification of preferred stock converted			$ 0	$ 0